{"study_id": 43616, "supplement_id": 1646, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 80, "study_goal": "The researchers aimed to evaluate the effects of valerian extract on improving sleep quality in postmenopausal women experiencing insomnia.", "results_summary": "The study found a statistically significant improvement in sleep quality in the valerian group compared to the placebo group, with 30% of the intervention group showing improvement versus 4% in the placebo group. The results support the clinical effectiveness of valerian for managing insomnia in this population.", "population_specificity": "Postmenopausal women aged 50-60 years experiencing insomnia.", "effective_dosage": "530 mg of concentrated valerian extract twice daily.", "study_duration": "4 weeks.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:33:54.979969+00:00"}
{"study_id": 43612, "supplement_id": 1646, "safety_score": "Not Assessed", "efficacy_score": 70, "quality_score": 80, "study_goal": "The researchers aimed to determine whether valerian extracts, standardized to different ratios of valerenic acid and acetoxy valerenic acid, exhibit anxiolytic and antidepressive effects in animal models.", "results_summary": "The valerian extract with a 12:1 ratio of valerenic acid to acetoxy valerenic acid showed significant anxiolytic effects at 0.5mg/kg, while the 1:1.5 ratio required a higher dose (2.0mg/kg). Neither extract demonstrated antidepressive effects, and the 1:1.5 ratio prolonged immobility, possibly due to reduced core body temperature rather than a depressive action.", "population_specificity": "Animal models (elevated plus maze test and tail suspension test).", "effective_dosage": "0.1, 0.5, 1.0, and 2.0mg/kg of valerian extracts.", "study_duration": "Not specified.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:33:55.042374+00:00"}
{"study_id": 43615, "supplement_id": 1646, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 80, "study_goal": "The researchers aimed to evaluate the impact of valerian on the severity of dysmenorrhea, focusing on its sedative and antispasmodic effects.", "results_summary": "Valerian significantly reduced pain severity in dysmenorrhea compared to placebo, with a statistically significant difference between groups. Systemic manifestations decreased overall, but only syncope showed a significant difference between groups.", "population_specificity": "100 female students with dysmenorrhea", "effective_dosage": "255 mg, 3 times daily for 3 days starting at menstruation onset", "study_duration": "2 consecutive menstrual cycles", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:33:55.113960+00:00"}
{"study_id": 43617, "supplement_id": 1646, "safety_score": "85", "efficacy_score": 45, "quality_score": 75, "study_goal": "The researchers aimed to evaluate the efficacy of a 450 mg Valerian officinalis supplement for improving sleep in cancer patients undergoing treatment.", "results_summary": "The study found no significant improvement in sleep quality as measured by the PSQI, but exploratory analyses showed improvements in secondary outcomes like fatigue and reduced drowsiness. No significant differences in toxicities were observed between valerian and placebo groups.", "population_specificity": "Cancer survivors undergoing cancer treatment.", "effective_dosage": "450 mg orally 1 hour before bedtime.", "study_duration": "8 weeks.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:33:58.350015+00:00"}
{"study_id": 43618, "supplement_id": 1646, "safety_score": "85", "efficacy_score": 75, "quality_score": 70, "study_goal": "The researchers aimed to compare the efficacy of Valeriana Officinalis L. extract with placebo in treating Obsessive-Compulsive Disorder (OCD).", "results_summary": "The study found a significant difference in efficacy between Valerian extract and placebo for OCD treatment, with somnolence being the only notable side effect. The results suggest Valerian has antiobsessive and compulsive effects, though further studies are needed.", "population_specificity": "Thirty-one adult outpatients meeting DSM-IV-TR criteria for OCD.", "effective_dosage": "765 mg/day of Valerian extract or 30 mg/day placebo.", "study_duration": "8 weeks.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:33:59.542144+00:00"}
{"study_id": 43620, "supplement_id": 1646, "safety_score": "Not Assessed", "efficacy_score": 65, "quality_score": 70, "study_goal": "The researchers aimed to evaluate the efficacy of valerian and hops in treating primary insomnia by reviewing existing studies.", "results_summary": "Twelve out of sixteen studies found that valerian, alone or combined with hops, improved some sleep parameters like sleep latency and quality, though results varied due to differences in study design. The conclusion calls for more rigorous trials before confident recommendations can be made.", "population_specificity": "Adults with primary insomnia.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:34:00.987049+00:00"}
{"study_id": 43619, "supplement_id": 1646, "safety_score": "80", "efficacy_score": 45, "quality_score": 70, "study_goal": "The researchers aimed to investigate the sedative effects of a valerian root extract and its single constituents (valerenic acid, linarin, and apigenin) on locomotor activity and core body temperature in mice.", "results_summary": "A 1000 mg/kg dose of valerian extract showed mild short-term sedative effects, while lower doses had no significant impact. Valerenic acid increased activity, whereas linarin and apigenin produced mild short-term sedation. Overall, neither the extract nor its compounds had considerable sedative effects over 180 minutes.", "population_specificity": "Male mice", "effective_dosage": "250-1000 mg/kg valerian extract; 1 mg/kg valerenic acid; 12 mg/kg linarin; 1.5 mg/kg apigenin", "study_duration": "180 minutes", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:34:02.433983+00:00"}
{"study_id": 43621, "supplement_id": 1646, "safety_score": "Not Assessed", "efficacy_score": 65, "quality_score": 80, "study_goal": "The researchers aimed to evaluate the effectiveness of Valerian for improving insomnia through a meta-analysis of randomized clinical trials.", "results_summary": "Valerian showed a subjective improvement in sleep quality (relative risk 1.37) but no significant quantitative or objective improvements in sleep latency or standardized sleep quality scores. Heterogeneity was present but reduced in subgroup analyses.", "population_specificity": "Individuals with insomnia (specific demographics not detailed).", "effective_dosage": "Not specified in the abstract.", "study_duration": "Not specified in the abstract.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:34:03.182830+00:00"}
{"study_id": 43623, "supplement_id": 1646, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 80, "study_goal": "The researchers aimed to compare the effects of 800 mg of valerian versus placebo on sleep quality and symptom severity in individuals with restless legs syndrome (RLS).", "results_summary": "The study found that 800 mg of valerian taken for 8 weeks improved RLS symptom severity and reduced daytime sleepiness, particularly in participants with higher baseline sleepiness (ESS score \u226510). A strong positive association was observed between improvements in sleepiness and RLS symptom severity.", "population_specificity": "Adults aged 36-65 years with restless legs syndrome.", "effective_dosage": "800 mg of valerian (frequency not specified).", "study_duration": "8 weeks.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:34:04.293048+00:00"}
{"study_id": 43622, "supplement_id": 1646, "safety_score": "85", "efficacy_score": 70, "quality_score": 60, "study_goal": "The researchers aimed to compare the effectiveness and tolerability of valerian-based combination therapies versus Neurexan for treating nervousness and restlessness in a CAM-favorable population.", "results_summary": "Valerian-based therapies significantly reduced nervousness/restlessness scores (from 21.4 to 12.6), though less than Neurexan (from 19.0 to 7.4). Both treatments were well tolerated, with no significant safety concerns reported.", "population_specificity": "224 subjects in German practices, predominantly with mild to moderate nervousness/restlessness, favoring CAM therapies.", "effective_dosage": "Not specified (physician's discretion)", "study_duration": "2 weeks", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:34:05.780241+00:00"}
{"study_id": 43624, "supplement_id": 1646, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to determine whether a single administration of a valerian/hops combination could effectively improve sleep in poor sleepers.", "results_summary": "The study found that a single dose of valerian/hops significantly increased time spent in sleep and deeper sleep compared to placebo, with statistically significant results (p<0.01). The EEG-derived parameter \"sleep quantity\" also showed superiority of the valerian/hops combination over placebo.", "population_specificity": "Poor sleepers identified by a validated sleep questionnaire (Schlaffragebogen SF-B).", "effective_dosage": "2 ml of liquid extract diluted in 50 ml water, administered once.", "study_duration": "Single administration.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:34:06.012952+00:00"}
{"study_id": 43626, "supplement_id": 1646, "safety_score": "70", "efficacy_score": 50, "quality_score": 75, "study_goal": "The researchers aimed to determine whether valerian, alone or in combination with haloperidol, affects liver or kidney function and oxidative stress parameters in rats.", "results_summary": "Valerian alone did not affect oxidative stress in liver or kidney tissues, but when combined with haloperidol, it increased lipid peroxidation and reactive species production in the liver. The combination also inhibited hepatic delta-ALA-D activity, suggesting potential adverse interactions.", "population_specificity": "Rats", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "Adverse interactions with haloperidol were noted.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:34:07.407839+00:00"}
{"study_id": 43625, "supplement_id": 1646, "safety_score": "85", "efficacy_score": 20, "quality_score": 75, "study_goal": "The researchers aimed to determine whether nightly valerian extract improves sleep in older women with insomnia.", "results_summary": "Valerian did not significantly improve sleep compared to placebo on measures of sleep latency, wake after sleep onset, sleep efficiency, or self-rated sleep quality. WASO increased significantly after 2 weeks of valerian use, but not with placebo.", "population_specificity": "Older women (mean age 69.4 years) with insomnia.", "effective_dosage": "300 mg nightly, 30 minutes before bedtime.", "study_duration": "2 weeks per treatment phase (crossover design).", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:34:08.110944+00:00"}
{"study_id": 43627, "supplement_id": 1646, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 70, "study_goal": "The researchers aimed to compare the effectiveness and tolerability of Neurexan and valerian in improving sleep parameters (latency, duration, and quality) in patients with mild to moderate insomnia.", "results_summary": "Valerian improved sleep latency (reduced by 38.2 min) and duration (increased by 2.0 h) by day 14, with no significant difference in sleep quality compared to Neurexan at day 28. However, Neurexan showed significantly better results in reducing daytime fatigue (49% vs. 32%).", "population_specificity": "Patients with mild to moderate insomnia treated across 89 German centers offering conventional and complementary therapies.", "effective_dosage": "Doses were at physicians' discretion (not specified).", "study_duration": "28 days", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:34:11.125378+00:00"}
{"study_id": 43628, "supplement_id": 1646, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to determine the effects of Valerian on 5-HT levels, cell proliferation, and neuron count in the hippocampus of rats with depression induced by chronic mild stress.", "results_summary": "Low- and medium-dose Valerian increased hippocampal 5-HT levels to normal, and low-dose Valerian restored BrdU-positive cell and neuron counts in depressed rats. Valerian may promote 5-HT levels and cell proliferation while protecting injured hippocampal neurons.", "population_specificity": "Rats with depression induced by chronic mild stress.", "effective_dosage": "Low, medium, and high doses (specific amounts not provided).", "study_duration": "3 weeks.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:34:11.736058+00:00"}
{"study_id": 43629, "supplement_id": 1646, "safety_score": "Not Assessed", "efficacy_score": 30, "quality_score": 75, "study_goal": "The researchers aimed to investigate the effects of valerian, alone and in combination with midazolam, on emergence time from isoflurane anesthesia in rats.", "results_summary": "The study found that rats given a combination of valerian and midazolam took significantly longer to emerge from anesthesia compared to other groups, indicating a potential interaction between valerian and midazolam that prolongs anesthetic recovery.", "population_specificity": "Male Sprague-Dawley rats", "effective_dosage": "Not specified", "study_duration": "Single administration (30 minutes before procedure)", "interactions": "Interaction with midazolam noted, prolonging emergence from isoflurane anesthesia.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:34:11.984012+00:00"}
{"study_id": 43630, "supplement_id": 1646, "safety_score": "90", "efficacy_score": 55, "quality_score": 80, "study_goal": "The researchers aimed to evaluate the safety and efficacy of Valerian for improving sleep quality in individuals with insomnia compared to placebo.", "results_summary": "Valerian showed a modest but statistically non-significant improvement in sleep quality (29% vs. 21% for placebo). A slight but significant benefit was noted in global self-assessment (5.5% more participants reported better sleep with Valerian). No serious adverse events were reported.", "population_specificity": "Adults aged 18-75 with insomnia in Norway.", "effective_dosage": "Not specified in the abstract.", "study_duration": "2 weeks.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:34:14.448801+00:00"}
{"study_id": 43631, "supplement_id": 1646, "safety_score": "85", "efficacy_score": 70, "quality_score": 75, "study_goal": "The researchers aimed to investigate the safety of valerian extract during pregnancy in rats, addressing the traditional contraindication despite a lack of supporting studies.", "results_summary": "The study found no adverse effects on fertility or fetal development in rats at doses up to 65 times the human dose, though toxicity was observed in embryo cultures with high extract concentrations. The low pH of the extract may have mitigated potential cytotoxicity.", "population_specificity": "Pregnant female rats", "effective_dosage": "Daily oral dosing of valerian extract in 45% ethanol (exact dosage not specified)", "study_duration": "Administered either on gestation days 1-8 or 8-15", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:34:14.926416+00:00"}
{"study_id": 43634, "supplement_id": 1646, "safety_score": "80", "efficacy_score": 30, "quality_score": 60, "study_goal": "The researchers aimed to investigate the effectiveness and safety of valerian for treating anxiety disorders compared to placebo and diazepam.", "results_summary": "The study found no significant differences in anxiety symptom scores between valerian and placebo or valerian and diazepam, except for greater symptom improvement in the diazepam group based on STAI-Trait scores. No significant differences in side effects or dropout rates were observed among the groups.", "population_specificity": "36 patients with generalized anxiety disorder.", "effective_dosage": "Not specified in the abstract.", "study_duration": "4 weeks.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:34:16.158969+00:00"}
{"study_id": 43633, "supplement_id": 1646, "safety_score": "85", "efficacy_score": 70, "quality_score": 60, "study_goal": "The researchers aimed to evaluate the effectiveness of valerian in improving sleep quality through a systematic review of randomized, placebo-controlled trials.", "results_summary": "The study found a statistically significant benefit of valerian in improving sleep quality (relative risk = 1.8), though there was evidence of publication bias. Most studies had methodological issues, but valerian appeared effective without reported side effects.", "population_specificity": "1093 patients across 16 studies, primarily adults with insomnia.", "effective_dosage": "Varied considerably across studies (not specified in abstract).", "study_duration": "Length of treatment varied (not specified in abstract).", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:34:16.360070+00:00"}
{"study_id": 43632, "supplement_id": 1646, "safety_score": "Not Assessed", "efficacy_score": 70, "quality_score": 85, "study_goal": "The researchers aimed to determine whether a fixed extract combination of valerian and hops (Ze 91019) was superior to placebo and a single valerian extract (Ze 911) in reducing sleep latency in patients with non-organic insomnia.", "results_summary": "The fixed valerian-hops extract combination significantly reduced sleep latency compared to placebo, while the single valerian extract did not show superiority over placebo. The results supported the plausibility of adding hops extract to valerian for improved efficacy.", "population_specificity": "Patients suffering from non-organic insomnia (ICD 10, F 51.0-51.2).", "effective_dosage": "500 mg valerian extract siccum (single extract) or 500 mg valerian extract siccum + 120 mg hops extract siccum (fixed combination).", "study_duration": "4 weeks.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:34:16.979821+00:00"}
{"study_id": 43635, "supplement_id": 1646, "safety_score": "30", "efficacy_score": 50, "quality_score": 70, "study_goal": "The researchers aimed to determine the genotoxic effects of valerian in somatic and germ cells of mice and investigate the role of epigenetic mechanisms.", "results_summary": "Valerian treatment increased micronuclei frequency, caused chromosomal aberrations, induced sperm abnormalities, and depleted nucleic acids in testicular cells, likely due to oxidative stress and epigenetic changes.", "population_specificity": "Mice (somatic and germ cells)", "effective_dosage": "500, 1000, and 2000 mg/kg/day", "study_duration": "7 days", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:34:19.282328+00:00"}
{"study_id": 43636, "supplement_id": 1646, "safety_score": "95", "efficacy_score": 85, "quality_score": 70, "study_goal": "The researchers aimed to evaluate the efficacy and tolerability of a combined valerian/lemon balm preparation in treating restlessness and nervous dyskoimesis in children under 12.", "results_summary": "The study found significant symptom reduction, with 80.9% improvement in dyssomnia and 70.4% in restlessness. Tolerability was rated as \"good\" or \"very good\" in 96.7% of cases, with no reported adverse events.", "population_specificity": "Children under 12 years suffering from restlessness and nervous dyskoimesis.", "effective_dosage": "Individually dosed by investigators (specific amounts not provided).", "study_duration": "Not specified in the abstract.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:34:20.898249+00:00"}
{"study_id": 43637, "supplement_id": 1646, "safety_score": "85", "efficacy_score": 65, "quality_score": 80, "study_goal": "The researchers aimed to evaluate the efficacy and safety of a valerian-hops combination compared to diphenhydramine and placebo for treating mild insomnia.", "results_summary": "The valerian-hops combination showed modest improvements in subjective sleep parameters and quality of life, with slightly greater reductions in sleep latency compared to placebo. No serious adverse events or rebound insomnia were observed.", "population_specificity": "184 adults (110 women, 74 men; mean age 44.3 years) with mild insomnia.", "effective_dosage": "Two nightly tablets of valerian (187-mg native extracts) and hops (41.9-mg native extracts).", "study_duration": "28 days.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:34:22.248587+00:00"}
{"study_id": 43639, "supplement_id": 1646, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 85, "study_goal": "The researchers aimed to determine novel mechanisms of action of valerian extracts, particularly their binding affinity to serotonin and other receptors implicated in sleep regulation.", "results_summary": "The study found that valerian extracts, especially petroleum ether and dichloromethane extracts, had strong binding affinity to the 5-HT(5a) receptor, suggesting a potential mechanism for its sleep-promoting effects. Valerenic acid, an active constituent, was identified as a partial agonist of this receptor.", "population_specificity": "Not specified (in vitro study)", "effective_dosage": "50 \u00b5g/ml for binding studies", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:34:23.687373+00:00"}
{"study_id": 43640, "supplement_id": 1646, "safety_score": "Not Assessed", "efficacy_score": 65, "quality_score": 50, "study_goal": "The researchers aimed to evaluate historical evidence supporting valerian's anticonvulsant effectiveness for treating epilepsy.", "results_summary": "The study found that valerian likely had potential anticonvulsant effects due to isovaleric acid, but its variable composition and unpleasant taste made it unsuitable for widespread use. Historical reports, including Fabio Colonna's account, supported its efficacy in some cases.", "population_specificity": "Epilepsy patients (historical reports, no specific modern cohort).", "effective_dosage": "High doses (specific amounts not quantified).", "study_duration": "Not specified.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:34:24.351253+00:00"}
{"study_id": 43641, "supplement_id": 1646, "safety_score": "80", "efficacy_score": 70, "quality_score": 60, "study_goal": "The researchers aimed to review the literature on Valerian's use in treating neuropsychiatric disorders, particularly its sedative and hypnotic effects in insomnia.", "results_summary": "Preclinical studies suggest Valerian has sedative and muscle-relaxant effects, with some clinical trials indicating subjective sleep improvement and few side effects. The mechanism of action may differ from benzodiazepines, potentially making it suitable for long-term use, but further rigorous trials are needed.", "population_specificity": "Not specified (general review of available literature).", "effective_dosage": "Not specified.", "study_duration": "Not specified.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:34:24.809193+00:00"}
{"study_id": 43638, "supplement_id": 1646, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 85, "study_goal": "The researchers aimed to study the metabolic changes and pharmacological effects of valerian extracts after incubation with rat hepatocytes, focusing on its interaction with GABA (A) receptor binding sites.", "results_summary": "Valerian extracts showed significant metabolic activity, with changes in sesquiterpenes and iridoids, but maintained similar binding affinities to GABA (A) receptor sites as non-incubated extracts. The study suggests that multiple compounds or other constituents may be responsible for the observed pharmacological effects.", "population_specificity": "Rat hepatocytes (in vitro study)", "effective_dosage": "Not specified", "study_duration": "4-hour incubation period", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:34:27.227880+00:00"}
{"study_id": 43644, "supplement_id": 1646, "safety_score": "85", "efficacy_score": 30, "quality_score": 75, "study_goal": "The researchers aimed to investigate the effectiveness of valerian for managing chronic insomnia in general practice by comparing it to placebo in n-of-1 trials.", "results_summary": "Valerian showed fair improvement in energy levels for most participants but was poor or modest for sleep time, night awakenings, and morning refreshment. No significant difference in side effects was found between valerian and placebo.", "population_specificity": "42 enrolled patients with chronic insomnia in Queensland, Australia (24 included in analysis).", "effective_dosage": "Not mentioned", "study_duration": "Not mentioned", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:34:27.452499+00:00"}
{"study_id": 43642, "supplement_id": 1646, "safety_score": "85", "efficacy_score": 65, "quality_score": 80, "study_goal": "The researchers aimed to assess whether valerian extract influences the activity of drug-metabolizing enzymes CYP2D6 and CYP3A4.", "results_summary": "The study found no significant effect of valerian on CYP2D6 activity but observed a modest increase in alprazolam's maximum plasma concentration (Cmax), suggesting a minor impact on CYP3A4. Overall, typical valerian doses were unlikely to produce clinically significant effects on CYP2D6 or CYP3A4-dependent medications.", "population_specificity": "Healthy volunteers (n = 12)", "effective_dosage": "Two 500-mg valerian tablets (1000 mg total) nightly", "study_duration": "14 days", "interactions": "Minor interaction with alprazolam (CYP3A4 substrate) but no significant effects on CYP2D6 or other CYP3A4 pharmacokinetic parameters.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:34:28.313827+00:00"}
{"study_id": 43646, "supplement_id": 1646, "safety_score": "90", "efficacy_score": 80, "quality_score": 70, "study_goal": "The researchers aimed to determine whether combining Valerian extract with St John's wort extract improves anxiety symptoms more effectively than St John's wort monotherapy in patients with depressive and anxiety disorders.", "results_summary": "The study found that combination therapy of Valerian and St John's wort significantly improved anxiety symptoms more quickly than St John's wort alone, with good tolerability and no significant side effects. Further research is needed to compare this combination with other treatments like serotonin- and noradrenalin re-uptake inhibitors.", "population_specificity": "Patients with depressive disorders comorbid with anxiety disorders.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:34:30.717024+00:00"}
{"study_id": 43645, "supplement_id": 1646, "safety_score": "70", "efficacy_score": 50, "quality_score": 80, "study_goal": "The researchers aimed to investigate the effects of valerian on rat liver and cultured human hepatoma cells, focusing on bile flow, liver function, and toxicity.", "results_summary": "Valerian showed no significant effects on bile flow, liver enzyme activity, or histology in rats, but high doses (20 mg/mL) caused increased cell death in human hepatoma cells. The study suggests potential in vitro toxicity at very high doses.", "population_specificity": "Rats and cultured human hepatoma cells.", "effective_dosage": "Acute doses (0.31-18.6 g/kg) and chronic dose (3.1 g/kg daily for 28 days) in rats; 2 mg/mL and 20 mg/mL in human hepatoma cells.", "study_duration": "Acute (24 h) and chronic (28 days).", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:34:30.853671+00:00"}
{"study_id": 43650, "supplement_id": 1646, "safety_score": "Not Assessed", "efficacy_score": 80, "quality_score": 75, "study_goal": "The researchers aimed to explore Valerian's potential for treating sleep problems in children with intellectual deficits (ID).", "results_summary": "Valerian treatment significantly reduced sleep latencies and nocturnal time awake, increased total sleep time, and improved sleep quality compared to baseline and placebo, particularly in children with hyperactivity-related deficits.", "population_specificity": "Children with varying intellectual deficits and primary sleep problems.", "effective_dosage": "Not specified", "study_duration": "8 weeks", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:34:31.739172+00:00"}
{"study_id": 43647, "supplement_id": 1646, "safety_score": "70", "efficacy_score": 60, "quality_score": 75, "study_goal": "The researchers aimed to assess the genotoxicity of valepotriates in vitro by analyzing DNA damage in human endothelial cells treated with dichloromethane extracts of valerian (DEV).", "results_summary": "No DNA damage was observed at low DEV concentrations (5-20 \u00b5g/mL), but moderate damage occurred at higher doses (40-60 \u00b5g/mL). Antioxidants (vitamin E and C) reduced DNA damage at low concentrations but increased it at high concentrations.", "population_specificity": "Human endothelial cell line ECV304", "effective_dosage": "5-60 \u00b5g/mL of DEV", "study_duration": "48 hours", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:34:32.143170+00:00"}
{"study_id": 43648, "supplement_id": 1646, "safety_score": "85", "efficacy_score": 90, "quality_score": 88, "study_goal": "The researchers aimed to compare the efficacy and safety of 600 mg/die valerian extract LI 156 (Sedonium) versus 10 mg/die oxazepam in treating non-organic insomnia.", "results_summary": "Valerian extract LI 156 was found to be at least as efficacious as oxazepam in improving sleep quality and related subscales, with both treatments significantly increasing sleep quality compared to baseline. Adverse events were mild to moderate, with fewer reported in the valerian group (28.4%) than the oxazepam group (36.0%).", "population_specificity": "Outpatients aged 18-73 years diagnosed with non-organic insomnia (ICD-10 F 51.0), with a mean insomnia duration of 3.5 months.", "effective_dosage": "600 mg/die valerian extract LI 156 (Sedonium).", "study_duration": "6 weeks.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:34:34.747946+00:00"}
{"study_id": 43652, "supplement_id": 1646, "safety_score": "75", "efficacy_score": 80, "quality_score": 65, "study_goal": "The researchers aimed to evaluate the effectiveness of valerian in treating stress-induced insomnia and compare its effects to kava.", "results_summary": "Valerian significantly relieved total stress severity and improved insomnia symptoms (time to fall asleep, hours slept, waking mood) with no significant differences compared to kava. Side effects were mild, with vivid dreams being the most common (16%).", "population_specificity": "19 patients suffering from stress-induced insomnia (originally 24, with 5 dropouts).", "effective_dosage": "600 mg daily", "study_duration": "6 weeks", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:34:35.688648+00:00"}
{"study_id": 43651, "supplement_id": 1646, "safety_score": "80", "efficacy_score": 70, "quality_score": 75, "study_goal": "The researchers aimed to evaluate the effects of valerian on sleep quality and structure in patients with insomnia who had withdrawn from chronic benzodiazepine use.", "results_summary": "Valerian improved subjective sleep quality and reduced wake time after sleep onset compared to placebo, but did not shorten sleep latency. Some sleep structure changes may have been influenced by benzodiazepine withdrawal rather than valerian itself.", "population_specificity": "19 patients with primary insomnia (mean age 43.3 years) who had used benzodiazepines nightly for an average of 7.1 years.", "effective_dosage": "Not specified", "study_duration": "15 days", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:34:35.745796+00:00"}
{"study_id": 43653, "supplement_id": 1646, "safety_score": "90", "efficacy_score": 80, "quality_score": 70, "study_goal": "The researchers aimed to evaluate the effects of a fixed extract combination of valerian and hop (Ze 91019) on sleep parameters in patients with mild-moderate, non-organic insomnia.", "results_summary": "The study found that after 2 weeks of treatment, sleep latency and wake time decreased, sleep efficiency increased, and slow wave sleep improved. Patients also reported feeling more refreshed in the morning. No adverse events were observed.", "population_specificity": "30 patients with mild-moderate, non-organic insomnia confirmed by polysomnography.", "effective_dosage": "2 tablets in the evening, each containing 250 mg valerian extract and 60 mg hop extract.", "study_duration": "2 weeks", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:34:37.417951+00:00"}
{"study_id": 43654, "supplement_id": 1646, "safety_score": "Not Assessed", "efficacy_score": 45, "quality_score": 70, "study_goal": "The researchers aimed to systematically review randomized, placebo-controlled, double-blind trials to evaluate the effects of valerian on insomnia.", "results_summary": "The study found contradictory and inconsistent results across the nine trials reviewed, with variations in patient populations, experimental designs, and methodological quality, concluding that evidence for valerian's efficacy in treating insomnia is inconclusive.", "population_specificity": "Human participants with insomnia (specific demographics not detailed).", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:34:38.581984+00:00"}
{"study_id": 43657, "supplement_id": 1646, "safety_score": "Not Assessed", "efficacy_score": 65, "quality_score": 75, "study_goal": "The researchers aimed to determine the effects of acute and repeated treatment with valerian extract on objective and subjective measures of sleep in elderly poor sleepers.", "results_summary": "Valerian increased slow-wave sleep (SWS) and decreased sleep stage 1, while K-complex density also increased. However, it had no effect on sleep onset time, time awake after sleep onset, REM sleep, or self-rated sleep quality.", "population_specificity": "Elderly poor sleepers (14 subjects, 8 in valerian group, 6 in placebo group).", "effective_dosage": "405 mg three times daily (t.i.d.).", "study_duration": "Seven days.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:34:40.881149+00:00"}
{"study_id": 43656, "supplement_id": 1646, "safety_score": "90", "efficacy_score": 85, "quality_score": 88, "study_goal": "The researchers aimed to determine whether Valerian root extract (VRE) impairs reaction time, alertness, and concentration the morning after single or repeated evening doses.", "results_summary": "The study found that a single dose of VRE (600 mg) did not impair reaction abilities, concentration, or coordination. After 14 days of treatment, VRE was equivalent to placebo in improving median reaction time, with no negative impact on cognitive functions.", "population_specificity": "102 male and female volunteers (99 analyzed for single-dose effects, 91 for repeated-dose effects).", "effective_dosage": "600 mg LI 156 (Valerian root extract) administered once or nightly for 14 days.", "study_duration": "Single dose and 14-day repeated administration.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:34:41.472683+00:00"}
{"study_id": 198536, "supplement_id": 1646, "safety_score": "Not Assessed", "efficacy_score": 70, "quality_score": 85, "study_goal": "The researchers aimed to determine whether valerian root extract (VRE) affects resting-state brain connectivity via EEG and whether these changes correlate with clinical anxiety and stress symptoms.", "results_summary": "Both VRE and placebo groups showed clinical improvements, but VRE uniquely increased frontal alpha coherence (linked to anxiolysis) and decreased theta coherence, suggesting altered brain connectivity related to anxiety. No significant between-group differences were found in clinical symptom improvements.", "population_specificity": "64 nonclinical volunteers experiencing psychological stress.", "effective_dosage": "100 mg thrice daily.", "study_duration": "4 weeks.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:34:43.045140+00:00"}
{"study_id": 43279, "supplement_id": 1647, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 90, "study_goal": "The researchers aimed to determine whether valine deprivation could trigger HDAC6 nuclear entry and DNA damage accumulation for potential targeted cancer therapy.", "results_summary": "The study found that valine deprivation induces HDAC6 entry into the nucleus, leading to DNA damage accumulation, which could be exploited for cancer treatment strategies.", "population_specificity": "Cancer-related research (specific population not detailed in abstract).", "effective_dosage": "Not mentioned", "study_duration": "Not mentioned", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:34:43.470907+00:00"}
{"study_id": 43277, "supplement_id": 1647, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 78, "study_goal": "The researchers aimed to evaluate the cytotoxic, genotoxic, and apoptotic effects of new hybrid cyclotriphosphazene compounds (including BV, BVK1, BVK2, and BVK4) on cancer cell lines.", "results_summary": "The compounds significantly reduced viability in A2780 and Caco-2 cancer cell lines, induced DNA damage, and showed strong binding affinity to cancer-related targets like Bcl-2, mutant p53, and VEGFR2, suggesting potential as multi-targeted cancer inhibitors.", "population_specificity": "A2780 and Caco-2 cancer cell lines (in vitro study).", "effective_dosage": "50-100 \u00b5M (high doses).", "study_duration": "Not specified.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:34:45.349046+00:00"}
{"study_id": 43280, "supplement_id": 1647, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 85, "study_goal": "The researchers aimed to determine whether valine restriction or branched-chain amino acid (BCAA) restriction could improve survival and metabolic outcomes in a Drosophila model of ECHS1D.", "results_summary": "Valine restriction, either alone or as part of BCAA restriction, extended larval survival in the ECHS1D fly model, suggesting reduced BCAA catabolic flux is beneficial. Metabolic profiling also indicated broader dysregulation beyond valine metabolism.", "population_specificity": "Drosophila (fruit fly) larvae with Echs1 mutations modeling human ECHS1D.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:34:46.238338+00:00"}
{"study_id": 43281, "supplement_id": 1647, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 90, "study_goal": "The researchers aimed to identify the mechanism by which cellular valine levels are sensed and how valine deprivation affects DNA damage and tumor growth.", "results_summary": "The study found that valine deprivation leads to HDAC6 retention in the nucleus, inducing DNA damage and inhibiting tumor growth in xenograft models. Dietary valine restriction also enhanced the efficacy of PARP inhibitors.", "population_specificity": "Xenograft and patient-derived xenograft models (not human subjects).", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:34:46.610434+00:00"}
{"study_id": 43285, "supplement_id": 1647, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 90, "study_goal": "The researchers aimed to determine whether valine degradation plays a critical role in mitochondrial succinate pool replenishment and lipid metabolism maintenance in prostate cancer.", "results_summary": "The study found that valine deprivation reduced lipid content and impaired malignant prostate cell proliferation, suggesting its role as a lipogenic fuel in prostate cancer. Inhibition of valine degradation decreased intracellular succinate and cellular respiration, highlighting a potential therapeutic target.", "population_specificity": "High-grade prostate tumors (prostate cancer cells).", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:34:49.566569+00:00"}
{"study_id": 43282, "supplement_id": 1647, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to investigate the role of low-dose valine supplementation in attenuating the progression of MASLD (metabolic dysfunction-associated steatotic liver disease) in mice.", "results_summary": "Low-dose valine supplementation attenuated MASLD progression by reducing body weight, liver weight, and eWAT weight, improving serum lipid profiles, enhancing leptin sensitivity, and modulating the gut microbiome. It also downregulated hepatic lipogenesis and cholesterol biosynthesis genes while upregulating fatty acid oxidation, autophagy, and antioxidant capacity genes.", "population_specificity": "C57BL/6J mice fed a high-fat/high-cholesterol diet to induce MASLD.", "effective_dosage": "Low-dose (specific amount not stated), administered voluntarily.", "study_duration": "Duration not explicitly stated in the abstract.", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:34:50.707606+00:00"}
{"study_id": 43286, "supplement_id": 1647, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 90, "study_goal": "The researchers aimed to determine the role of valine aminoacyl-tRNA synthetase (VARS) in codon-biased translation reprogramming and its potential as a therapeutic target in MAPK therapy-resistant melanoma.", "results_summary": "The study found that VARS upregulation in resistant melanoma promotes valine-enriched transcript translation, including hydroxyacyl-CoA dehydrogenase, which supports fatty acid oxidation and survival. VARS knockdown re-sensitized resistant melanoma to MAPK therapy in vitro and in vivo.", "population_specificity": "Patient-derived MAPK therapy-resistant melanoma cells and models.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:34:51.803215+00:00"}
{"study_id": 43292, "supplement_id": 1647, "safety_score": "30", "efficacy_score": 65, "quality_score": 75, "study_goal": "The researchers aimed to investigate the effects of l-valine supplementation on male reproduction and its underlying molecular mechanisms in mice.", "results_summary": "l-valine supplementation altered testis cell morphology, induced apoptosis, reduced gene expression related to autophagy and methylation, and disrupted multiple signaling pathways, leading to structural damage in mouse testis.", "population_specificity": "Male mice", "effective_dosage": "0.30% or 0.45% in drinking water", "study_duration": "3 weeks", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:34:54.375357+00:00"}
{"study_id": 43288, "supplement_id": 1647, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 85, "study_goal": "The researchers aimed to compare the efficacy and stability of a novel trastuzumab-MMAU ADC with a valine-citrulline conjugated trastuzumab ADC (trastuzumab-vc-MMAE) in HER2+ tumor models.", "results_summary": "The trastuzumab-MMAU ADC demonstrated superior stability, resistance to cleavage, and antitumor efficacy compared to the valine-citrulline conjugated ADC (trastuzumab-vc-MMAE), with higher tolerated doses and improved pharmacokinetics in nonhuman primates.", "population_specificity": "HER2+ xenograft models and cynomolgus monkeys (cyno).", "effective_dosage": "1 or 2 mg/kg (DAR 8 and 4, respectively) for efficacy; up to 12 mg/kg for toxicity in cyno.", "study_duration": "Not specified in the abstract.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:34:55.537323+00:00"}
{"study_id": 43290, "supplement_id": 1647, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 78, "study_goal": "The researchers aimed to determine the role of transporters (RcAAP2, RcANT7, and RcLHT1) in the phloem-loading and translocation of L-Val-PCA (a valine conjugate) in Ricinus plants.", "results_summary": "The study found that RcAAP2, RcANT7, and RcLHT1 facilitated L-Val-PCA uptake and phloem translocation, with significant decreases in phloem sap concentrations after silencing and increases after overexpression. The transporters were localized to the plasma membrane of mesophyll and phloem cells.", "population_specificity": "Ricinus (castor) plants", "effective_dosage": "Not specified", "study_duration": "72 hours (post-silencing/overexpression)", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:34:56.807937+00:00"}
{"study_id": 43294, "supplement_id": 1647, "safety_score": "85", "efficacy_score": 90, "quality_score": 80, "study_goal": "The researchers aimed to evaluate the effectiveness of valine-conjugated chitosan nanocarriers co-loaded with rivastigmine and quercetin for Alzheimer's disease treatment, focusing on brain targeting and biocompatibility.", "results_summary": "The study found that RV/QT-NCs@VLCS significantly improved memory recovery, reduced GSH depletion, and modulated key biomarkers (BDNF, ACHE, TNF-\u03b1) more effectively than single-drug delivery. The nanocarrier demonstrated superior efficacy and biocompatibility in both in vitro and in vivo models.", "population_specificity": "HEK-293 and SH-SY5Y cells, rats (animal model).", "effective_dosage": "Not specified in the abstract.", "study_duration": "Not specified in the abstract.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:34:58.399926+00:00"}
{"study_id": 43287, "supplement_id": 1647, "safety_score": "30", "efficacy_score": 75, "quality_score": 80, "study_goal": "The researchers aimed to investigate the molecular mechanism of valine's detrimental effects on metabolic health, focusing on its impact on lipid metabolism, gut microbiota, and inflammation.", "results_summary": "Valine treatment enhanced hepatic lipid metabolism and adipogenesis, increased ileal villus height and crypt depth, disturbed signaling pathways in adipose tissues, altered gut microbiota composition, and elevated inflammation-related metabolites and genes.", "population_specificity": "Lean mice", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:34:58.465500+00:00"}
{"study_id": 43296, "supplement_id": 1647, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 78, "study_goal": "The researchers aimed to develop and evaluate N-substituted N-arylsulfonamido d-valines as matrix metalloproteinase inhibitors (MMPIs) for therapeutic and imaging applications.", "results_summary": "The study found that the synthesized Valine derivatives were potent inhibitors of MMP-2 and MMP-9 (nanomolar range), with some compounds showing promise for PET and fluorescence imaging applications. The lead compound and its derivatives demonstrated significant inhibitory activity, particularly against MMP-2 and MMP-9.", "population_specificity": "In vitro study (no human or animal subjects specified).", "effective_dosage": "Not specified.", "study_duration": "Not specified.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:34:59.704747+00:00"}
{"study_id": 43655, "supplement_id": 1646, "safety_score": "90", "efficacy_score": 75, "quality_score": 85, "study_goal": "The researchers aimed to assess the short-term and long-term effects of valerian extract on objective and subjective sleep parameters in patients with psychophysiological insomnia.", "results_summary": "After multiple-dose treatment, valerian increased sleep efficiency and slow-wave sleep while reducing its latency, with fewer adverse events compared to placebo. Subjective sleep latency also showed improvement under valerian treatment.", "population_specificity": "16 patients (4 male, 12 female) with psychophysiological insomnia, median age 49 (range: 22-55).", "effective_dosage": "Not specified in the abstract.", "study_duration": "14 days (long-term effects).", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:35:00.552973+00:00"}
{"study_id": 43297, "supplement_id": 1647, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 85, "study_goal": "The researchers aimed to determine whether the valine metabolite 3-HIB and the enzyme HIBCH regulate hepatic lipid accumulation and their role in insulin resistance and type 2 diabetes.", "results_summary": "The study identified a regulatory feedback loop between the valine/3-HIB pathway and PDK4 that influences hepatic fatty acid metabolism. HIBCH overexpression increased fatty acid uptake, while knockdown improved cellular respiration and reduced reactive oxygen species, implicating this pathway in fatty liver disease.", "population_specificity": "Human liver biopsies (Liver cohort) and plasma samples (CARBFUNC cohort), as well as Huh7 hepatocytes.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:35:01.072589+00:00"}
{"study_id": 43298, "supplement_id": 1647, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to identify the VQ gene family in *B. oleracea* and analyze the role of *BoVQ25-1* in pollen germination.", "results_summary": "The study identified 64 *BoVQ* genes in *B. oleracea*, with *BoVQ25-1* preferentially expressed in anthers and localized to the nucleus. Suppressing *BoVQ25-1* significantly reduced pollen germination rates.", "population_specificity": "*Brassica oleracea* (specifically the cultivar 'Fast Cycle')", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:35:03.314357+00:00"}
{"study_id": 43300, "supplement_id": 1647, "safety_score": "85", "efficacy_score": 80, "quality_score": 75, "study_goal": "The researchers aimed to determine whether valine enhances the mammary gland defense system by increasing antimicrobial component production without affecting milk production or tight junction barrier function.", "results_summary": "Valine increased the secretion of antimicrobial components (S100A7, lactoferrin, \u03b2-defensin 1, and cathelicidin 7) in cultured mammary epithelial cells and in the milk of lactating goats, without altering milk yield, composition, or tight junction function.", "population_specificity": "Cultured mammary epithelial cells (in vitro) and lactating Tokara goats (in vivo).", "effective_dosage": "4 mM in vitro; intravenous injection in vivo (exact dosage not specified).", "study_duration": "Not specified.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:35:05.060484+00:00"}
{"study_id": 43304, "supplement_id": 1647, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 85, "study_goal": "The researchers aimed to identify novel therapeutic targets against Klebsiella pneumoniae infection by analyzing metabolic differences, particularly focusing on L-valine catabolism in clinical isolates.", "results_summary": "The study found increased catabolism of L-valine in clinical isolate-specific growth simulations of K. pneumoniae, suggesting potential efficacy of targeting valine transaminase inhibition as a therapeutic strategy.", "population_specificity": "In vitro laboratory and clinical isolates of Klebsiella pneumoniae.", "effective_dosage": "Not available", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:35:06.230209+00:00"}
{"study_id": 43302, "supplement_id": 1647, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 90, "study_goal": "The researchers aimed to determine if valine levels could serve as biomarkers for improved liver metabolism in response to dapagliflozin treatment.", "results_summary": "The study found that valine levels increased significantly in plasma and liver tissue in both animal models and human patients treated with dapagliflozin, suggesting its potential as a biomarker for improved liver metabolism.", "population_specificity": "Obesity and diabetes mouse model, and patients with type 2 diabetes.", "effective_dosage": "Not specified", "study_duration": "One week (clinical study)", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:35:06.430746+00:00"}
{"study_id": 43309, "supplement_id": 1647, "safety_score": "30", "efficacy_score": 75, "quality_score": 80, "study_goal": "The researchers aimed to evaluate the diagnostic potential of valine metabolite analysis in patients with ECHS1 deficiency and assess the impact of valine restriction on neurological symptoms.", "results_summary": "The study identified specific valine-derived metabolites in urine and plasma that distinguished ECHS1-deficient patients from controls, suggesting these biomarkers could aid early diagnosis and dietary therapy evaluation. Valine accumulation was linked to cytotoxicity, supporting the need for dietary restriction.", "population_specificity": "Six patients with ECHS1 deficiency (four new cases) and six normal controls.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:35:09.059853+00:00"}
{"study_id": 43310, "supplement_id": 1647, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 90, "study_goal": "The researchers aimed to determine whether valine, in combination with TDCA, could mitigate obesity-induced inflammation and improve transplant outcomes in diet-induced obese mice.", "results_summary": "Valine, combined with TDCA, prolonged allograft survival, dampened Th1 and Th17 immune responses, increased Treg frequencies and IL-10 production, and reduced donor-specific antibodies by restraining M1-macrophage polarization via TGR5 signaling.", "population_specificity": "Diet-induced obese (DIO) mice undergoing organ transplantation.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:35:09.647323+00:00"}
{"study_id": 43308, "supplement_id": 1647, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 90, "study_goal": "The researchers aimed to determine the standardized ileal digestible (SID) Val:Lys requirement for pigs fed diets containing 30% DDGS and compare growth performance to pigs fed a corn-soybean meal diet.", "results_summary": "Increasing the SID Val:Lys ratio in 30% DDGS diets improved growth metrics (BW, ADG, ADFI, G:F), with optimal ratios varying by phase (70-75%). Pigs fed corn-SBM diets outperformed those on DDGS diets regardless of Val:Lys ratio.", "population_specificity": "Pigs (initially 39.4 kg, DNA 600 \u00d7 Topigs Norsvin 70 breed).", "effective_dosage": "SID Val:Lys ratios of 60%, 65%, 70%, 75%, and 80%.", "study_duration": "28 days.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:35:10.768858+00:00"}
{"study_id": 43311, "supplement_id": 1647, "safety_score": "60", "efficacy_score": 80, "quality_score": 85, "study_goal": "The researchers aimed to determine the effects of long-term dietary valine on gut health and the development of nonalcoholic fatty liver disease (NAFLD) in laying hens.", "results_summary": "Valine supplementation improved gut health by enhancing intestinal barrier function and reducing pathogenic bacteria, but high levels (0.74% and 0.79%) accelerated NAFLD development by promoting lipogenesis and inhibiting fatty acid oxidation.", "population_specificity": "33-week-old laying hens", "effective_dosage": "0.59%, 0.64%, 0.69%, 0.74%, and 0.79% dietary valine", "study_duration": "8 weeks", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:35:12.588955+00:00"}
{"study_id": 43312, "supplement_id": 1647, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 80, "study_goal": "The researchers aimed to compare protein synthesis rates in juvenile red drum fed a control diet versus a valine-deficient diet to assess the impact of valine on protein accretion.", "results_summary": "A one-time feeding of a valine-deficient diet significantly reduced protein synthesis rates in red drum muscle, with peak synthesis rates observed at 12 hours post-feeding, declining thereafter. The study demonstrated the sensitivity of deuterium methodologies in detecting dietary-induced changes in protein synthesis.", "population_specificity": "Juvenile red drum (initially weighing ~4.5 g/fish)", "effective_dosage": "Not specified", "study_duration": "Single feeding followed by measurements over 48 hours", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:35:14.351121+00:00"}
{"study_id": 43314, "supplement_id": 1647, "safety_score": "Not Assessed", "efficacy_score": 70, "quality_score": 60, "study_goal": "The researchers aimed to describe a new metabolic disorder (HIBADH deficiency) linked to valine degradation and assess the effectiveness of a low-valine diet in reducing 3HiB excretion.", "results_summary": "The study identified two patients with HIBADH deficiency, showing that a low-valine diet rapidly decreased 3HiB excretion in urine. However, clinical phenotype variability and limited patient numbers suggest further evaluation is needed.", "population_specificity": "Two patients with HIBADH deficiency (a metabolic disorder affecting valine degradation).", "effective_dosage": "Not specified (low-valine diet only).", "study_duration": "Not specified.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:35:15.268948+00:00"}
{"study_id": 43313, "supplement_id": 1647, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 78, "study_goal": "The researchers aimed to assess the impact of varying dietary valine levels on production performance, egg quality, immunity, and intestinal amino acid absorption in laying hens during peak lay.", "results_summary": "Increasing dietary valine levels improved egg mass, laying rate, and feed conversion ratio but negatively affected egg weight, eggshell thickness, and serum markers like CAT, IgA, and IgM. Valine supplementation enhanced certain amino acid transporters and serum free amino acids while downregulating others.", "population_specificity": "33-week-old Fengda No.1 laying hens", "effective_dosage": "0.59%, 0.64%, 0.69%, 0.74%, and 0.79% dietary valine", "study_duration": "8 weeks", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:35:15.995346+00:00"}
{"study_id": 43318, "supplement_id": 1647, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to evaluate the antiatherogenic potential of valine by assessing its impact on triglyceride levels in hypercholesterolemic rats.", "results_summary": "Valine significantly reduced triglyceride levels compared to cholesterol-fed controls, with a more pronounced and rapid effect than leucine. The results suggest valine positively influences lipid metabolism.", "population_specificity": "Male Wistar rats (250-280 g)", "effective_dosage": "Not specified", "study_duration": "60 days", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:35:16.827921+00:00"}
{"study_id": 43319, "supplement_id": 1647, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to determine the optimal dietary valine levels for maximizing feed intake, body weight, and egg output in Japanese quail.", "results_summary": "Feed intake and body weight peaked at 6.66 g Val/kg diet, while egg output reached 9.5 g/bird/day at the same dosage. Valine requirements were estimated at 10.6 mg/g of egg output and 159 mg/kg body weight for maintenance.", "population_specificity": "Japanese quail (280 birds, divided into eight treatment groups).", "effective_dosage": "1.97 to 9.85 g Val/kg diet.", "study_duration": "Not specified in the abstract.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:35:19.462478+00:00"}
{"study_id": 43320, "supplement_id": 1647, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 85, "study_goal": "The researchers aimed to explore the regulatory roles of Valine-glutamine (VQ) proteins and their interactions with WRKY transcription factors in plant responses to oxygen-related processes and nitric oxide modulation.", "results_summary": "The study identified differentially expressed VQ and WRKY genes involved in hypoxia, ozone-triggered oxidative stress, and nitric oxide responses, suggesting these proteins form regulatory complexes for gasotransmitter-modulated processes in plants.", "population_specificity": "Arabidopsis thaliana (plant model organism)", "effective_dosage": "Not available", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:35:20.856108+00:00"}
{"study_id": 43321, "supplement_id": 1647, "safety_score": "30", "efficacy_score": 20, "quality_score": 75, "study_goal": "The researchers aimed to determine whether valine supplementation could reduce obesity and metabolic syndrome in mice, similar to other branched-chain amino acids like leucine.", "results_summary": "Valine supplementation increased serum triglyceride and insulin levels in chow diet-fed mice and worsened metabolic parameters (body weight, glucose intolerance, fat oxidation genes) in high-fat diet-fed mice. It did not suppress lipid deposition or metabolic disorders.", "population_specificity": "Mice (n = 10 per group) fed either a chow diet or high-fat diet.", "effective_dosage": "3% (w/v) valine in drinking water.", "study_duration": "Not specified in the abstract.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:35:22.909074+00:00"}
{"study_id": 43322, "supplement_id": 1647, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to determine the regulatory effects of valine on peach tree growth, particularly its inhibition of new shoot growth and its impact on root growth, photosynthetic rate, and fruit quality.", "results_summary": "Valine significantly inhibited peach seedling growth, promoted root growth, improved net photosynthetic rate and fruit quality, and reduced gibberellin content. It also altered gene expression related to growth regulation and disrupted branched-chain amino acid balance, though isoleucine supplementation could mitigate some inhibitory effects.", "population_specificity": "Peach tree seedlings", "effective_dosage": "10 g\u22c5L-1", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:35:24.191955+00:00"}
{"study_id": 43323, "supplement_id": 1647, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 80, "study_goal": "The researchers aimed to investigate the metabolism of valine in human-induced pluripotent stem cell-derived astrocytes and HepG2 cells to assess its potential role in increasing downstream metabolites beneficial for traumatic brain injury outcomes.", "results_summary": "The study found that a significant proportion of ibHB and 2-KIV in both HepG2 cells and iPSC-derived astrocytes originated from valine, suggesting valine supplementation could enhance these metabolites. These findings support valine's potential role in optimizing nutritional interventions for traumatic brain injury.", "population_specificity": "Human-induced pluripotent stem cell-derived astrocytes and HepG2 cells (in vitro study).", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:35:26.216895+00:00"}
{"study_id": 43324, "supplement_id": 1647, "safety_score": "70", "efficacy_score": 65, "quality_score": 50, "study_goal": "The researchers aimed to evaluate the therapeutic effects of valine restriction, cysteamine, and NAC in patients with ECHS1 deficiency (ECHS1D) to mitigate neurodegeneration and improve neurological outcomes.", "results_summary": "Valine restriction reduced excretion of toxic metabolites and improved neurological outcomes in one sibling, while cysteamine and NAC did not prevent Leigh syndrome in the other. Early dietary intervention showed better results compared to delayed treatment.", "population_specificity": "Two siblings with ECHS1 deficiency presenting Leigh syndrome.", "effective_dosage": "Not specified (low protein diet and valine-restricted diet).", "study_duration": "Varied (elder sister started at 4 years, younger brother at 14 months).", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:35:26.488994+00:00"}
{"study_id": 43326, "supplement_id": 1647, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 78, "study_goal": "The researchers aimed to evaluate the efficacy of \u03b3-glutamyl valine (\u03b3-EV) in reducing tumor necrosis factor-\u03b1-induced inflammatory responses in endothelial cells via calcium-sensing receptor (CaSR)-mediated pathways.", "results_summary": "Pretreatment with 1 mM \u03b3-EV significantly reduced inflammatory adhesion molecules (VCAM-1 and E-selectin) and cytokines (IL-8 and IL-6), with effects attenuated by CaSR inhibition, indicating CaSR-mediated anti-inflammatory action. Transport efficiency of \u03b3-EV was also confirmed in intestinal epithelial cells.", "population_specificity": "Human aortic endothelial cells (HAoECs) and intestinal epithelial cells (Caco-2).", "effective_dosage": "0.01, 0.1, and 1 mM \u03b3-EV.", "study_duration": "2-hour pretreatment.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:35:29.553347+00:00"}
{"study_id": 43328, "supplement_id": 1647, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 80, "study_goal": "The researchers aimed to evaluate the synthesis and biological effects of valine-naphthoquinone derivatives, particularly their potential in inhibiting cell proliferation in tumorigenic versus non-tumorigenic cells.", "results_summary": "Valine-naphthoquinone derivatives were synthesized with 80-92% yield and showed redox activity. The study observed differential effects of chloride and non-chloride derivatives in tumorigenic cells, suggesting potential for cervical cancer treatment, though valine-specific efficacy was less highlighted compared to other amino acids.", "population_specificity": "Tumorigenic (SiHa, CaLo, C33-A) and non-tumorigenic (HaCaT) cell lines, simulating precancerous and cancerous statuses.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:35:30.997603+00:00"}
{"study_id": 43329, "supplement_id": 1647, "safety_score": "85", "efficacy_score": 78, "quality_score": 72, "study_goal": "The researchers aimed to evaluate the effects of Valine (VAL) on milk protein synthesis-related and energy-mediated cellular signaling in bovine mammary epithelial (MAC-T) cells.", "results_summary": "VAL up-regulated sodium-dependent neutral amino acids transporter type 2 (ASCT2) and \u03b2-casein expression (173% and 218%, respectively) and showed differential stimulatory effects on energy metabolism and transcriptional pathways compared to Phenylalanine (PHE).", "population_specificity": "Immortalized bovine mammary epithelial (MAC-T) cells.", "effective_dosage": "0.6 mM VAL (optimal concentration identified).", "study_duration": "Not specified in the abstract.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:35:31.465303+00:00"}
{"study_id": 43330, "supplement_id": 1647, "safety_score": "Not Assessed", "efficacy_score": 30, "quality_score": 75, "study_goal": "The researchers aimed to determine if valine independently promotes insulin resistance and affects the ability of cells to degrade branched-chain amino acids (BCAAs).", "results_summary": "Valine did not alter insulin sensitivity or worsen insulin resistance in myotubes, nor did it affect mitochondrial biogenesis or glycolysis. However, it reduced Bckdha mRNA expression, which was exacerbated by insulin resistance.", "population_specificity": "C2C12 myotubes (in vitro skeletal muscle model)", "effective_dosage": "0.5 mM to 2 mM", "study_duration": "Up to 48 hours", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:35:32.656505+00:00"}
{"study_id": 43334, "supplement_id": 1647, "safety_score": "Not Assessed", "efficacy_score": null, "quality_score": 75, "study_goal": "The researchers aimed to explore the potential role of valine in destabilizing the HbS red blood cell cytoskeleton and triggering sickle cell disease crises.", "results_summary": "The abstract suggests a possible pathophysiological mechanism involving valine's interaction with glucose on the HbS molecule, potentially leading to destabilization of the red blood cell cytoskeleton and SCD crises, but does not present direct experimental results.", "population_specificity": "Patients with sickle cell disease (SCD).", "effective_dosage": "Not mentioned", "study_duration": "Not mentioned", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:35:34.488372+00:00"}
{"study_id": 43332, "supplement_id": 1647, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 80, "study_goal": "The researchers aimed to determine the effects of dietary valine supplementation on mammary gland development in late gestation gilts and its subsequent impact on piglet growth and colostrum composition.", "results_summary": "Increasing dietary valine to lysine ratio to 0.93 improved piglet weight and average daily gain at weaning, enhanced colostrum composition, and promoted mammary gland development, as evidenced by increased prolactin levels and activation of the mTOR signaling pathway. No effects were observed on litter size or weight at farrowing.", "population_specificity": "Primiparous gilts (pregnant pigs)", "effective_dosage": "Total dietary valine to lysine ratios of 0.63 (LV), 0.73 (MV), and 0.93 (HV)", "study_duration": "From day 75 of gestation until farrowing", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:35:36.518846+00:00"}
{"study_id": 43316, "supplement_id": 1647, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 78, "study_goal": "The researchers aimed to determine whether restored levels of valine contribute to weight loss effects similar to those observed after sleeve gastrectomy and to explore its mechanism of action.", "results_summary": "The study found that systemic treatment with valine induced significant weight loss comparable to sleeve gastrectomy, primarily by reducing food intake via central inhibition of melanin-concentrating hormone (MCH). Valine levels were significantly reduced in obese mice and restored post-surgery.", "population_specificity": "Diet-induced obese (DIO) mice and lean mice.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:35:38.345224+00:00"}
{"study_id": 43335, "supplement_id": 1647, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 80, "study_goal": "The researchers aimed to assess circulating valine concentrations in type 2 diabetes (T2D) patients and HFD-fed mice treated with sitagliptin (Sit) and analyze its association with metabolic parameters.", "results_summary": "Plasma valine concentrations were significantly higher in T2D patients compared to healthy controls and were positively correlated with fasting plasma glucose levels. Sit treatment notably reduced valine levels in both T2D patients and HFD-fed mice, suggesting a potential hypoglycemic mechanism.", "population_specificity": "Subjects with normal glucose levels (n=19), newly diagnosed T2D (n=20), placebo-treated T2D (n=7), and Sit-treated T2D (n=7), as well as HFD-fed mice.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:35:39.734380+00:00"}
{"study_id": 43301, "supplement_id": 1647, "safety_score": "Not Assessed", "efficacy_score": 65, "quality_score": 75, "study_goal": "The researchers aimed to determine the effect of increasing dietary valine levels on performance parameters, egg quality, and blood/serum components in laying quails.", "results_summary": "Increasing valine levels reduced egg weight, egg mass, and Haugh unit but improved eggshell breaking strength and reduced serum glucose and triglycerides. White blood cell counts increased, while erythrocyte and hematocrit levels decreased.", "population_specificity": "Female Japanese quails (10 weeks old, 241.4 \u00b1 8.6 g)", "effective_dosage": "0.93% (control), 1.00%, 1.10%, 1.20%, 1.30%, or 1.40% valine in diet", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:35:40.144988+00:00"}
{"study_id": 43336, "supplement_id": 1647, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 90, "study_goal": "The researchers aimed to explore the role of HIBCH in colorectal cancer (CRC) progression and resistance to anti-VEGF therapy, and to develop a valine catabolism inhibitor (SBF-1) as a potential therapy.", "results_summary": "High HIBCH expression was linked to poor CRC survival, increased cell growth, and resistance to apoptosis. SBF-1 inhibited HIBCH, reducing cancer growth and enhancing autophagy, and improved the efficacy of anti-VEGF therapy.", "population_specificity": "Patients with colorectal cancer (CRC) and CRC cell lines.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "Anti-VEGF therapy (bevacizumab) increased HIBCH levels, and SBF-1 counteracted this effect.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:35:40.904819+00:00"}
{"study_id": 43338, "supplement_id": 1647, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 80, "study_goal": "The researchers aimed to determine if N-terminal valine adducts could be used to monitor differences in DEB formation in patients receiving treosulfan as part of a conditioning regimen for stem cell transplantation.", "results_summary": "The study found that treosulfan treatment significantly increased pyr-Val and THB-Val adducts in patients, demonstrating the method's ability to quantify both background and treosulfan-induced adducts. The results were statistically significant (p <0.0001).", "population_specificity": "14 transplant recipients with hematological malignancies.", "effective_dosage": "Not specified in the abstract.", "study_duration": "Blood samples were collected before treatment and 6 days after treatment.", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:35:41.519460+00:00"}
{"study_id": 43339, "supplement_id": 1647, "safety_score": "30", "efficacy_score": null, "quality_score": 75, "study_goal": "The researchers aimed to evaluate the relationship between valine-citrulline-monomethylauristatin E antibody-drug conjugates (ADCs) exposure and the risk of developing clinically significant peripheral neuropathy (PN).", "results_summary": "The study found that the risk of grade \u2265 2 PN increased with ADC exposure, treatment duration, body weight, and prior PN history. The model developed can inform clinical strategies to reduce PN incidence.", "population_specificity": "Approximately 700 patients across eight ADCs developed at Genentech.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:35:42.531707+00:00"}
{"study_id": 43341, "supplement_id": 1647, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to evaluate the anti-glioblastoma activity of L-valine derived boroxazolidones, particularly compound 6, compared to the standard drug Temozolomide (TMZ).", "results_summary": "Compound 6 showed higher cytotoxicity than TMZ, with dose-dependent growth inhibition (IC50 of 49\u202f\u03bcM and 53\u202f\u03bcM for LN229 and SNB19 cells, respectively). It induced apoptosis, activated caspase 3/7, increased reactive oxygen species production, and caused G2/M phase arrest in glioblastoma cell lines.", "population_specificity": "Human glioblastoma cell lines (LN229 and SNB19).", "effective_dosage": "IC50 values of 49\u202f\u03bcM (LN229) and 53\u202f\u03bcM (SNB19).", "study_duration": "Not specified.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:35:48.754940+00:00"}
{"study_id": 43337, "supplement_id": 1647, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to evaluate the anti-Leishmania amazonensis effects of the peptidomimetic compound 157, which contains valine/leucine substituents, and its impact on parasite physiology and macrophage interaction.", "results_summary": "The compound 157 induced significant morphological and ultrastructural changes in L. amazonensis, disrupted plasma membrane permeability, and perturbed mitochondrial transmembrane potential, leading to parasite death. It also reduced macrophage association and intramacrophage amastigote numbers with an IC50 of 30.2 \u03bcM, showing good selective toxicity.", "population_specificity": "Leishmania amazonensis promastigotes and amastigotes, and RAW macrophages (in vitro study).", "effective_dosage": "IC50 value of 30.2 \u03bcM for amastigotes (specific dosage frequency not mentioned).", "study_duration": "72 hours for amastigote reduction (intervention duration for other effects not specified).", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:35:51.698546+00:00"}
{"study_id": 43340, "supplement_id": 1647, "safety_score": "Not Assessed", "efficacy_score": 30, "quality_score": 75, "study_goal": "The researchers aimed to evaluate the ideal standardized ileal digestible (SID) Val:Lys ratio for sow and litter performance during lactation.", "results_summary": "Increasing SID Val:Lys ratios did not significantly affect sow feed intake, wean-to-estrus interval, litter growth rate, sow weight loss, or subsequent total born. No improvements in reproductive performance or piglet growth were observed.", "population_specificity": "430 sows (parity 1, 2, and 3+) during an 18.6-day lactation period.", "effective_dosage": "SID Val:Lys ratios of 0.50, 0.62, 0.75, 0.88, and 1.00 in corn-soybean meal-based diets.", "study_duration": "From 112 days of pregnancy through a 23-day lactation period.", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:36:29.145567+00:00"}
{"study_id": 199487, "supplement_id": 1663, "safety_score": "Not Assessed", "efficacy_score": 65, "quality_score": 70, "study_goal": "The researchers aimed to determine the prevalence of vitamin D deficiency among prison inmates worldwide.", "results_summary": "The pooled prevalence of vitamin D deficiency was 55%, while 29.41% had insufficient levels, indicating a high deficiency rate among prisoners. The study concluded that regular evaluations and supplementation are crucial.", "population_specificity": "Prison inmates", "effective_dosage": "Not available", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:36:36.675282+00:00"}
{"study_id": 199484, "supplement_id": 1663, "safety_score": "Not Assessed", "efficacy_score": 65, "quality_score": 70, "study_goal": "The researchers aimed to explore the potential relationship between vitamin D deficiency and erectile dysfunction, examining possible mechanisms and summarizing meta-analytic evidence for this association.", "results_summary": "The study suggests that low vitamin D levels may worsen erectile function through mechanisms like endothelial dysfunction and comorbidity interference, but clinical trial quality and heterogeneity prevent definitive conclusions.", "population_specificity": "Elderly males with erectile dysfunction and potential vitamin D deficiency.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:36:37.477877+00:00"}
{"study_id": 199481, "supplement_id": 1663, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 85, "study_goal": "The researchers aimed to assess the effect of different doses of vitamin D supplementation on serum 25(OH)D concentrations in preschool children.", "results_summary": "The study evaluated the impact of vitamin D supplementation at varying doses but did not report specific results in the provided abstract.", "population_specificity": "Preschool children aged 12-30 months in Mexico.", "effective_dosage": "Vitamin D2 (Ergocalciferol) 400 IU/day (other doses not specified in the abstract).", "study_duration": "Not specified in the abstract.", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:36:37.494510+00:00"}
{"study_id": 199489, "supplement_id": 1663, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 85, "study_goal": "The researchers aimed to analyze the influence of vitamin D supplementation on asthma prevention and treatment across different life stages, from gestation to adulthood.", "results_summary": "Vitamin D supplementation during pregnancy reduced wheezing occurrence in children by 23%. The study found varying results depending on the patient's life period, suggesting further investigation is needed for asthma management.", "population_specificity": "Pregnant women, infants, children, and adults (as part of the included randomized clinical trials).", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:36:37.618172+00:00"}
{"study_id": 199482, "supplement_id": 1663, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 80, "study_goal": "The researchers aimed to examine the correlation between vitamin D deficiency and the development of atrial fibrillation, particularly after cardiac surgery, and to review the potential mechanisms and outcomes of this relationship.", "results_summary": "The study found that vitamin D supplementation reduces the risk of atrial fibrillation, with significant differences between control and study groups in pre- and postoperative periods. However, the exact mechanisms remain unclear, and the topic is still debated due to conflicting results.", "population_specificity": "Patients undergoing cardiac surgery, particularly those with vitamin D deficiency.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:36:38.342057+00:00"}
{"study_id": 199483, "supplement_id": 1663, "safety_score": "Not Assessed", "efficacy_score": 65, "quality_score": 75, "study_goal": "The researchers aimed to explore factors influencing heterogeneity in Vitamin D therapy response and propose targeted populations for future interventions in the context of T2DM.", "results_summary": "The study found mixed and contradictory results regarding Vitamin D supplementation's role in T2DM prevention and treatment, with preclinical models supporting its pleiotropic benefits. Deficient subjects showed greater risk for T2DM and enhanced response to therapy, but many questions remain unanswered.", "population_specificity": "Individuals at risk for or diagnosed with type 2 diabetes mellitus (T2DM).", "effective_dosage": "Not available", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:36:38.454706+00:00"}
{"study_id": 199485, "supplement_id": 1663, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 85, "study_goal": "The researchers aimed to determine the effects of vitamin D supplementation on hormone levels (LH, FSH, LH/FSH ratio) and menstrual cycle regularity in women with PCOS.", "results_summary": "Vitamin D supplementation reduced serum LH levels and improved menstrual cycle regularity, particularly at dosages >4000 IU/day and treatment durations >8 weeks, but had no significant effect on FSH or LH/FSH levels.", "population_specificity": "Women with polycystic ovary syndrome (PCOS) (849 patients across 12 studies).", "effective_dosage": "\u22644000 IU/day and >4000 IU/day.", "study_duration": "\u22648 weeks and >8 weeks.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:36:38.693731+00:00"}
{"study_id": 199488, "supplement_id": 1663, "safety_score": "Not Assessed", "efficacy_score": 80, "quality_score": 75, "study_goal": "The researchers aimed to compare the efficacy of broadband ultraviolet B radiation (UVBR) versus a moderate loading dose of vitamin D in improving postural control and cognitive functions in patients with relapsing-remitting multiple sclerosis (RRMS).", "results_summary": "Both UVBR and vitamin D showed highly significant improvements in postural control (OSI) and cognitive function (SDMT), with no statistically significant differences between the two treatments. Clinically, UVBR was more convenient due to shorter treatment time and higher percentage of change.", "population_specificity": "40 patients with relapsing-remitting multiple sclerosis (RRMS) from both genders.", "effective_dosage": "Moderate loading dose (specific amount not provided).", "study_duration": "4 weeks.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:36:39.116328+00:00"}
{"study_id": 199490, "supplement_id": 1663, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to systematically review the relationship between vitamin D and DNA damage across various populations.", "results_summary": "The majority of studies showed that vitamin D prevents DNA damage and mitigates existing damage, though two studies found no association and one study reported a specific effect only in cord blood. Vitamin D was concluded to have a protective effect against DNA damage.", "population_specificity": "Humans (12 studies, including experimental and observational designs) and animals (13 in vivo studies).", "effective_dosage": "Not available", "study_duration": "Not available", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:36:44.533547+00:00"}
{"study_id": 199491, "supplement_id": 1663, "safety_score": "Not Assessed", "efficacy_score": 70, "quality_score": 65, "study_goal": "The researchers aimed to review the role of nutrition, including Vitamin D, in improving malnutrition and muscle mass in stroke-related sarcopenia.", "results_summary": "The study suggests that supplementation with whey protein combined with Vitamin D may improve malnutrition status, increase muscle mass, and delay or prevent stroke-related sarcopenia. However, no specific efficacy data on Vitamin D alone were provided.", "population_specificity": "Patients with stroke-related sarcopenia.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:36:45.091739+00:00"}
{"study_id": 199493, "supplement_id": 1663, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to determine the effects of vitamin D supplementation on proteinuria and creatinine levels in patients with Diabetic Kidney Disease.", "results_summary": "Vitamin D supplementation (50,000 I.U./week for 8 weeks) effectively reduced proteinuria and creatinine levels in patients with Diabetic Kidney Disease, particularly those with Diabetes Mellitus type 2, by influencing inflammatory markers. However, more clinical trials are needed to confirm these findings in larger populations.", "population_specificity": "Patients with Diabetic Kidney Disease, especially those with Diabetes Mellitus type 2.", "effective_dosage": "50,000 I.U./week", "study_duration": "8 weeks", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:36:46.410016+00:00"}
{"study_id": 199496, "supplement_id": 1663, "safety_score": "Not Assessed", "efficacy_score": null, "quality_score": 85, "study_goal": "The researchers aimed to investigate the effects of vitamin D supplementation on the gut microbiome using data from a randomized controlled trial.", "results_summary": "The abstract does not provide specific results regarding the effects of vitamin D on the gut microbiome or other outcomes.", "population_specificity": "Australians aged 60-84 years.", "effective_dosage": "60,000 IU of vitamin D (frequency not specified).", "study_duration": "Not specified in the abstract.", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:36:46.557286+00:00"}
{"study_id": 199494, "supplement_id": 1663, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 65, "study_goal": "The researchers aimed to examine the relationship between serum vitamin D levels and COVID-19 infection and severity in pregnant women.", "results_summary": "The study found that vitamin D deficiency is common in pregnant women with COVID-19, and lower serum vitamin D levels correlated with increased disease severity. Vitamin D levels were also linked to the occurrence and symptoms of COVID-19, suggesting prenatal supplementation may be beneficial.", "population_specificity": "Pregnant women (COVID-19-positive and COVID-19-negative).", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:36:47.009783+00:00"}
{"study_id": 199497, "supplement_id": 1663, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 80, "study_goal": "The researchers aimed to investigate the effect of vitamin D administration on the survival rate of Plasmodium-infected animals in experimentally-induced malaria.", "results_summary": "The meta-analysis found a statistically significant positive effect of vitamin D on survival rates in infected mice on day 6 post-infection, though the clinical relevance for humans remains uncertain due to differences between mouse models and human malaria.", "population_specificity": "Plasmodium-infected mice", "effective_dosage": "Not specified", "study_duration": "Assessed on days 6 and 10 post-infection", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:36:47.044745+00:00"}
{"study_id": 199492, "supplement_id": 1663, "safety_score": "85", "efficacy_score": 20, "quality_score": 90, "study_goal": "The researchers aimed to determine whether a high daily dose of 2,000 IU vitamin D improves musculoskeletal outcomes in generally healthy older adults.", "results_summary": "The study found no benefit of 2,000 IU/d vitamin D on nonvertebral fractures, falls, functional decline, or frailty. In a subcohort, it also did not improve bone density, structure, or physical performance.", "population_specificity": "Generally healthy adults (men \u226550 years, women \u226555 years in VITAL; men and women \u226570 years in DO-HEALTH).", "effective_dosage": "2,000 IU daily", "study_duration": "5.3 years (VITAL), 3 years (DO-HEALTH)", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:36:47.282425+00:00"}
{"study_id": 199495, "supplement_id": 1663, "safety_score": "85", "efficacy_score": 80, "quality_score": 90, "study_goal": "The researchers aimed to determine whether higher plasma 25-hydroxyvitamin D levels are associated with improved outcomes in stage III colon cancer patients and if inflammatory cytokines mediate this association.", "results_summary": "Nondeficient vitamin D status (\u226512 ng/mL) was significantly associated with improved disease-free survival, overall survival, and time to recurrence, with a U-shaped dose-response pattern observed. The association was partially mediated by sTNF-R2 but not by CRP or IL6, and no significant adverse events were reported.", "population_specificity": "1,437 patients with stage III colon cancer enrolled in a phase III randomized clinical trial (CALGB/SWOG 80702).", "effective_dosage": "Not specified (plasma levels \u226512 ng/mL considered nondeficient).", "study_duration": "Follow-up until 2020 (samples collected from 2010 to 2015).", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:36:49.736281+00:00"}
{"study_id": 199498, "supplement_id": 1663, "safety_score": "Not Assessed", "efficacy_score": 65, "quality_score": 70, "study_goal": "The researchers aimed to analyze the effects of vitamin D deficiency on female reproductive health, considering environmental factors and climate change impacts.", "results_summary": "The study found that vitamin D deficiency, influenced by latitude and environmental factors, negatively impacts pregnant women and their children, but supplementation guidelines were underdeveloped, and research gaps existed for at-risk groups.", "population_specificity": "Women living at latitudes higher than 40\u00b0 N and 40\u00b0 S, primarily from North America and Europe.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:36:52.898426+00:00"}
{"study_id": 199499, "supplement_id": 1663, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 90, "study_goal": "The researchers aimed to determine the association between maternal vitamin D levels at delivery and the mode of delivery, including potential indirect effects through complications like preeclampsia and preterm delivery.", "results_summary": "The study found that moderate and severe vitamin D deficiency at delivery was associated with higher probabilities of cesarean section, preeclampsia, and preterm delivery compared to normal vitamin D levels.", "population_specificity": "1,649 eligible pregnant women from the Khuzestan Vitamin D Deficiency Screening Program in Pregnancy.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:36:53.451509+00:00"}
{"study_id": 199501, "supplement_id": 1663, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 85, "study_goal": "The researchers aimed to evaluate the effects of Vitamin D on inflammatory biomarkers in patients with cancer or pre-cancerous conditions.", "results_summary": "Vitamin D significantly reduced TNF-\u03b1 levels and showed non-significant reductions in IL-6 and CRP levels, while IL-10 levels remained unchanged. The study suggests potential benefits of Vitamin D in suppressing tumor-promoting inflammation.", "population_specificity": "Patients with cancer or pre-cancerous conditions (total of 592 participants).", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:36:54.161248+00:00"}
{"study_id": 199504, "supplement_id": 1663, "safety_score": "Not Assessed", "efficacy_score": null, "quality_score": 85, "study_goal": "The researchers aimed to determine whether high-dose vitamin D supplementation reduces the incidence and severity of COVID-19 infections in healthcare workers in high-risk areas.", "results_summary": "The abstract does not provide specific results regarding the impact of vitamin D supplementation on COVID-19 infection rates or severity.", "population_specificity": "Healthcare workers (HCWs) in high COVID-19 incidence areas.", "effective_dosage": "One oral loading dose of 100,000 IU vitamin D.", "study_duration": "Not specified in the abstract.", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:36:55.176920+00:00"}
{"study_id": 199505, "supplement_id": 1663, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 78, "study_goal": "The researchers aimed to investigate the association between vitamin D deficiency and vasovagal syncope (VVS) by analyzing existing studies.", "results_summary": "The meta-analysis found that VVS patients had significantly lower vitamin D levels compared to non-VVS cases (SMD -1.05, p < .01) and that vitamin D-deficient individuals had higher VVS occurrence (OR 5.43, p < .01).", "population_specificity": "Patients with vasovagal syncope (VVS).", "effective_dosage": "Not available", "study_duration": "Not available", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:36:55.480154+00:00"}
{"study_id": 199500, "supplement_id": 1663, "safety_score": "Not Assessed", "efficacy_score": 65, "quality_score": 75, "study_goal": "The researchers aimed to summarize the role of vitamin D in Alzheimer's disease (AD) and review the results of supplementation trials in AD patients.", "results_summary": "The abstract suggests that vitamin D influences immune-mediated A\u03b2 plaque clearance, immune response, oxidative stress, and mitochondrial function, which are relevant in AD pathogenesis, but notes that genomic vitamin D signaling is impaired in the AD brain. The results of supplementation trials are reviewed but not detailed in the abstract.", "population_specificity": "Alzheimer's disease patients", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:36:56.002024+00:00"}
{"study_id": 199502, "supplement_id": 1663, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to evaluate the efficacy of vitamin D supplementation in preventing postoperative atrial fibrillation (POAF) in patients undergoing coronary artery bypass grafting (CABG).", "results_summary": "The study found that vitamin D significantly reduced the incidence of POAF (RR: 0.60; 95% CI: 0.40, 0.90; p = 0.01). Secondary outcomes such as ICU stay, hospital stay, and other complications were also analyzed but not detailed in the abstract.", "population_specificity": "Patients undergoing CABG surgery.", "effective_dosage": "Not specified in the abstract.", "study_duration": "Not specified in the abstract.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:36:56.356886+00:00"}
{"study_id": 199506, "supplement_id": 1663, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 85, "study_goal": "The researchers aimed to examine the effect of vitamin D supplementation on serum heat-shock proteins (HSP) in postmenopausal women.", "results_summary": "Vitamin D supplementation increased serum HSP27 levels (both phosphorylated and total forms) but had no effect on HSP60, HSP70/72, or HSP90\u03b1 levels.", "population_specificity": "Postmenopausal women aged 45-65 with amenorrhea for 12 months or more.", "effective_dosage": "1,000 IU Vitamin D3 daily", "study_duration": "10 months", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:36:57.771026+00:00"}
{"study_id": 199508, "supplement_id": 1663, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 85, "study_goal": "The researchers aimed to investigate the genetic correlation and causal relationship between genetically determined vitamin D levels and COVID-19 risk.", "results_summary": "The study found a significant genetic correlation between genetically predicted vitamin D levels and COVID-19 risk, suggesting a potential causal relationship. Cross-trait GWAS meta-analysis identified overlapping susceptibility loci between vitamin D and COVID-19.", "population_specificity": "Large-scale genome-wide association study (GWAS) participants (specific population not detailed in the abstract).", "effective_dosage": "Not mentioned", "study_duration": "Not mentioned", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:37:00.569821+00:00"}
{"study_id": 199509, "supplement_id": 1663, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 85, "study_goal": "The researchers aimed to determine whether weekly oral supplementation with 10,000 IU vitamin D could influence QFT-Plus results in children.", "results_summary": "The study randomized 829 QFT-Plus-negative children to vitamin D and 853 to placebo, but the abstract does not provide conclusive efficacy results regarding the primary outcome.", "population_specificity": "Children attending 23 primary schools in Cape Town.", "effective_dosage": "10,000 IU weekly.", "study_duration": "Not specified in the abstract.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:37:01.785666+00:00"}
{"study_id": 199513, "supplement_id": 1663, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 80, "study_goal": "The researchers aimed to assess the effects of whey protein supplementation alone or combined with vitamin D on lean mass, strength, and function in older adults with or without sarcopenia or frailty.", "results_summary": "Co-supplementation with vitamin D significantly enhanced lean mass gains, muscle strength, and physical function, particularly in healthy older adults, likely due to correcting vitamin D insufficiency or deficiency. Whey protein alone improved outcomes in sarcopenic/frail older adults but had no effect in healthy individuals.", "population_specificity": "Older adults with or without sarcopenia or frailty.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:37:04.114215+00:00"}
{"study_id": 199512, "supplement_id": 1663, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 80, "study_goal": "The researchers aimed to determine the effect of vitamin D supplementation on proinflammatory cytokine levels and CD68 expression in children with chronic tonsillitis associated with vitamin D deficiency.", "results_summary": "Vitamin D supplementation significantly increased serum 25(OH)D levels, reduced proinflammatory cytokines (TNF\u03b1, IL-2), and decreased CD68 immunoexpressing cells compared to placebo. It also alleviated tonsil histological damage, suggesting a protective role against chronic tonsillitis.", "population_specificity": "80 children with chronic tonsillitis and vitamin D deficiency.", "effective_dosage": "50,000 IU weekly", "study_duration": "3-6 months", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:37:04.194114+00:00"}
{"study_id": 199510, "supplement_id": 1663, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 85, "study_goal": "The researchers aimed to determine the impact of high-dose (1200 IU) versus standard-dose (400 IU) vitamin D3 supplementation during the first 2 years of life on psychiatric symptoms at ages 6 to 8 years, and whether this impact differed based on maternal vitamin D levels.", "results_summary": "The study found that high-dose vitamin D3 supplementation (1200 IU) reduced the risk of internalizing problems at ages 6 to 8 years compared to the standard dose (400 IU), particularly in children with lower maternal vitamin D levels. No differences were observed in externalizing or total problems between the groups.", "population_specificity": "Term-born infants in Helsinki, Finland, followed up at ages 6 to 8 years.", "effective_dosage": "400 IU or 1200 IU oral vitamin D3 daily.", "study_duration": "From ages 2 weeks to 24 months.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:37:04.526609+00:00"}
{"study_id": 199516, "supplement_id": 1663, "safety_score": "Not Assessed", "efficacy_score": 65, "quality_score": 80, "study_goal": "The researchers aimed to evaluate the effect of vitamin D supplementation on 25(OH)D levels and metabolic/cardiovascular outcomes in overweight and obese children and adolescents.", "results_summary": "Vitamin D supplementation slightly increased 25(OH)D levels by 1.6 ng/ml compared to placebo, but effects on metabolic and cardiovascular outcomes were inconsistent.", "population_specificity": "Overweight and obese children and adolescents", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:37:04.711782+00:00"}
{"study_id": 199517, "supplement_id": 1663, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 80, "study_goal": "The researchers aimed to determine the effect of vitamin D supplementation on functional outcomes (motor function, mobility, activities of daily living, and stroke impairment) in post-stroke individuals.", "results_summary": "The majority of studies showed statistical improvement in motor function, mobility, and stroke impairment with vitamin D supplementation, but no significant improvement in activities of daily living. Clinical significance of these findings remains uncertain.", "population_specificity": "Adult stroke patients", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:37:05.562242+00:00"}
{"study_id": 199515, "supplement_id": 1663, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 78, "study_goal": "The researchers aimed to assess the association between vitamin D levels at diagnosis of lymphoid malignancies and patient outcomes, including survival.", "results_summary": "The study found significant associations between low vitamin D levels and worse outcomes in lymphoid malignancies, including higher disease progression risk and lower survival probability. Supplemental vitamin D improved chemosensitivity and had protective effects in certain treatments like R-CHOP for DLBCL.", "population_specificity": "4503 patients with lymphoid malignancies, median age 56.5 years.", "effective_dosage": "Not specified", "study_duration": "Median follow-up duration of approximately 36 months", "interactions": "Impairment of rituximab treatment and worse outcomes in CAR-T recipients were noted with vitamin D insufficiency.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:37:06.112505+00:00"}
{"study_id": 199518, "supplement_id": 1663, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 80, "study_goal": "The researchers aimed to investigate Vitamin D's preventive and therapeutic effects on the occurrence and remission of carpal tunnel syndrome (CTS) symptoms.", "results_summary": "Vitamin D supplementation improved functional scores, nerve conduction, and pain in CTS patients, while low Vitamin D levels worsened symptoms. Some studies found no significant link between low Vitamin D and higher pain scores. Vitamin D's effects may involve regulating cell proliferation, nerve growth, oxidative stress, inflammation, and microvascular damage.", "population_specificity": "Patients with carpal tunnel syndrome (CTS)", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:37:09.391949+00:00"}
{"study_id": 199519, "supplement_id": 1663, "safety_score": "85", "efficacy_score": 40, "quality_score": 75, "study_goal": "The researchers aimed to evaluate the pleiotropic effects of vitamin D supplementation, focusing on its potential benefits beyond bone health and the challenges in demonstrating these effects in clinical trials.", "results_summary": "The study found that while preclinical and observational data suggest vitamin D may have broad health benefits, most randomized clinical trials failed to demonstrate positive effects of supplementation. Future research needs to address methodological limitations to better assess vitamin D's potential benefits.", "population_specificity": "General population, with a focus on frail populations.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:37:10.487316+00:00"}
{"study_id": 199523, "supplement_id": 1663, "safety_score": "Not Assessed", "efficacy_score": 65, "quality_score": 75, "study_goal": "The researchers aimed to explore the association between vitamin D deficiency and disease severity in patients with COVID-19.", "results_summary": "The study found that vitamin D deficiency was associated with increased disease severity in COVID-19 patients, suggesting a potential role in modulating outcomes. However, the abstract does not provide detailed efficacy data on vitamin D supplementation.", "population_specificity": "Patients with COVID-19.", "effective_dosage": "Not specified.", "study_duration": "Not specified.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:37:12.525952+00:00"}
{"study_id": 199521, "supplement_id": 1663, "safety_score": "Not Assessed", "efficacy_score": 65, "quality_score": 70, "study_goal": "The researchers aimed to evaluate the potential role of vitamin D in protecting against COVID-19 and long COVID-19, particularly in unvaccinated and at-risk populations.", "results_summary": "Epidemiological studies indicated that individuals deficient in vitamin D may have increased susceptibility to severe COVID-19 outcomes, suggesting a potential protective effect of vitamin D. The abstract implies a correlation but does not provide conclusive evidence of causation or detailed efficacy.", "population_specificity": "Individuals at risk of COVID-19, particularly those with vitamin D deficiency.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:37:12.531732+00:00"}
{"study_id": 199520, "supplement_id": 1663, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to determine whether combining aerobic exercise and vitamin D supplementation could improve psychiatric comorbidities (depression, sleep quality, physical self-concept) in men with migraine and vitamin D insufficiency.", "results_summary": "The study found that combining aerobic exercise with vitamin D supplementation significantly reduced depression severity, improved sleep quality, and enhanced physical self-concept compared to exercise alone, vitamin D alone, or placebo.", "population_specificity": "Men with migraine and vitamin D insufficiency.", "effective_dosage": "Not specified in the abstract.", "study_duration": "8 weeks.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:37:13.447108+00:00"}
{"study_id": 199524, "supplement_id": 1663, "safety_score": "60", "efficacy_score": 30, "quality_score": 85, "study_goal": "The researchers aimed to determine whether intermittent or single high-dose vitamin D supplementation affects the risk of falls and fractures in adults.", "results_summary": "The meta-analysis found no significant preventive effect of high-dose vitamin D on falls or fractures and suggested a potential increase in fall risk. The pooled relative risk for falls was 1.03 (95% CI, 0.98-1.09).", "population_specificity": "Adults (specific age or health status not detailed in the abstract).", "effective_dosage": "High-dose (specific amounts not detailed in the abstract).", "study_duration": "Not specified in the abstract.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:37:13.973109+00:00"}
{"study_id": 199525, "supplement_id": 1663, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 85, "study_goal": "The researchers aimed to evaluate the role of serum 25-hydroxy vitamin D3 levels as a risk factor for recompression of augmented vertebrae after percutaneous kyphoplasty in osteoporotic vertebral fracture patients.", "results_summary": "Lower levels of serum 25-hydroxy vitamin D3 were identified as an independent risk factor for recompression. Vitamin D supplementation was suggested as a potential benefit for high-risk patients, alongside other antiosteoporotic therapies.", "population_specificity": "Patients who underwent percutaneous kyphoplasty for single thoracolumbar osteoporotic vertebral fractures (T10-L2).", "effective_dosage": "Not specified", "study_duration": "Follow-up of at least 2 years", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:37:14.986232+00:00"}
{"study_id": 199526, "supplement_id": 1663, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 90, "study_goal": "The researchers aimed to evaluate the effect of exercise programs combined with dietary supplementation, including Vitamin D, on body composition and muscle-related outcomes in sarcopenic older adults.", "results_summary": "The study found that Vitamin D supplementation, when combined with resistance exercise and other dietary supplements (essential amino acids or whey protein), improved muscle mass, strength, and quality of life indicators in sarcopenic older adults, suggesting a synergistic effect.", "population_specificity": "Sarcopenic older adults", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:37:17.120958+00:00"}
{"study_id": 199527, "supplement_id": 1663, "safety_score": "Not Assessed", "efficacy_score": 60, "quality_score": 85, "study_goal": "The researchers aimed to assess the effects of vitamin D supplementation on clinical and imaging outcomes in patients with multiple sclerosis (MS).", "results_summary": "Most studies reported no significant effect of vitamin D supplementation on relapse events or disability progression, but recent RCTs found a significant reduction in new MRI lesions in MS patients during vitamin D3 supplementation.", "population_specificity": "Patients with multiple sclerosis (MS).", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:37:17.649821+00:00"}
{"study_id": 199528, "supplement_id": 1663, "safety_score": "Not Assessed", "efficacy_score": 65, "quality_score": 85, "study_goal": "The researchers aimed to determine the impact of vitamin D supplementation on cardiovascular outcomes and mortality risk reduction in adults.", "results_summary": "Vitamin D supplementation was associated with a lower risk of all-cause mortality but did not show a decrease in specific cardiovascular morbidity or mortality risk. The effect was more convincing in fair- and good-quality RCTs.", "population_specificity": "Adults (mean age 66.1 years, 68.6% female)", "effective_dosage": "Not specified", "study_duration": "Follow-up period longer than one year", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:37:20.414106+00:00"}
{"study_id": 199529, "supplement_id": 1663, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 70, "study_goal": "The researchers aimed to analyze how vitamin D's immune-modulatory effects influence COVID-19 pathophysiology and explore a potential link between seasonal vitamin D fluctuations and COVID-19 epidemiology, particularly in the elderly.", "results_summary": "Vitamin D modulates both innate and adaptive immunity, potentially reducing COVID-19 severity by suppressing pro-inflammatory responses and enhancing antiviral defenses. A pilot trial showed calcifediol reduced ICU needs in hospitalized COVID-19 patients, though larger studies are needed for confirmation.", "population_specificity": "Elderly population and hospitalized COVID-19 patients.", "effective_dosage": "Not specified (oral calcifediol used in pilot trial, but dosage not detailed).", "study_duration": "Not specified.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:37:21.676902+00:00"}
{"study_id": 199530, "supplement_id": 1663, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 70, "study_goal": "The researchers aimed to assess the effect of moderate- to high-dose vitamin D supplementation during pregnancy on offspring bone mineral density (BMD) in childhood.", "results_summary": "The meta-analysis found that vitamin D supplementation during pregnancy increased offspring BMD at age 4-6 years, with a smaller effect on bone mineral content (BMC). No effect was observed in the neonatal period.", "population_specificity": "Pregnant women and their offspring (assessed in neonatal period and early childhood, 3-6 years).", "effective_dosage": "Varied across studies (moderate- to high-dose; 2 studies used 400 IU/day cholecalciferol as control).", "study_duration": "Duration of pregnancy (exact length not specified).", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:37:22.709224+00:00"}
{"study_id": 199531, "supplement_id": 1663, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 90, "study_goal": "The researchers aimed to assess the effect of vitamin D supplementation during pregnancy on glucose levels and identify factors influencing the response to vitamin D3 intake.", "results_summary": "Vitamin D supplementation (1600 IU/d) stabilized fasting plasma glucose levels in pregnant women, particularly in those with specific genetic polymorphisms, higher baseline 25(OH)D levels, or metabolic conditions like GDM, overweight, or multiple pregnancies. The control group (400 IU/d) showed a significant increase in glucose levels.", "population_specificity": "1720 pregnant women from three antenatal clinics in Hefei, China, at 24-28 weeks' gestation.", "effective_dosage": "1600 IU/d (intervention) and 400 IU/d (control).", "study_duration": "2 months.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:37:24.220051+00:00"}
{"study_id": 199532, "supplement_id": 1663, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 85, "study_goal": "The researchers aimed to determine whether prenatal vitamin D supplementation's efficacy in preventing early-life asthma or recurrent wheezing in offspring depends on maternal baseline vitamin D status and the timing of supplementation initiation.", "results_summary": "The study found that prenatal vitamin D supplementation showed a trend toward reducing asthma or recurrent wheezing, with the greatest effect in severely vitamin D-deficient women. Earlier initiation of supplementation (first trimester) was associated with higher efficacy in reducing offspring asthma or recurrent wheezing.", "population_specificity": "Pregnant women (10-18 weeks gestation at enrollment) and their offspring followed until age 6.", "effective_dosage": "4400 IU/day (intervention) vs. 400 IU/day (placebo).", "study_duration": "Supplementation began at 10-18 weeks gestation and continued until delivery.", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:37:24.633609+00:00"}
{"study_id": 199533, "supplement_id": 1663, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 80, "study_goal": "The researchers aimed to summarize recent advances in vitamin D cancer research, focusing on its molecular mechanisms and translational potential across cancer types.", "results_summary": "The study found that vitamin D deficiency is linked to increased cancer risk and progression, while supplementation may improve clinical outcomes, especially when combined with chemo/immunotherapy. Epigenomic, transcriptomic, and proteomic studies revealed vitamin D's role in regulating cancer cell processes and immune system interactions.", "population_specificity": "General cancer research (no specific population mentioned).", "effective_dosage": "Not specified.", "study_duration": "Not specified.", "interactions": "Mentioned potential combination with chemo/immunotherapeutic drugs.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:37:25.606343+00:00"}
{"study_id": 199534, "supplement_id": 1663, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 65, "study_goal": "The researchers aimed to explore the potential role of vitamin D deficiency in depression and suicide and assess the benefits of vitamin D supplementation in reducing these risks.", "results_summary": "The study suggests that vitamin D deficiency may be a relevant risk factor for depression and suicide, with supplementation showing promising adjunctive effects by potentially enhancing serotonin synthesis and modulating inflammation.", "population_specificity": "General population, with a focus on individuals with depression or suicide risk.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:37:25.802418+00:00"}
{"study_id": 199535, "supplement_id": 1663, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 80, "study_goal": "The researchers aimed to explore the role of vitamin D/VDR signaling in modulating innate immune responses, microbiota regulation, and its potential therapeutic effects in inflammatory bowel disease and acute respiratory distress syndrome.", "results_summary": "The study found that vitamin D/VDR signaling regulates intestinal and respiratory microbiota, enhances barrier function, and promotes antimicrobial peptide production, suggesting potential benefits in diseases marked by excessive inflammation and dysbiosis.", "population_specificity": "Not specified (general review of mechanisms and clinical diseases)", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:37:28.413654+00:00"}
{"study_id": 199536, "supplement_id": 1663, "safety_score": "70", "efficacy_score": 60, "quality_score": 75, "study_goal": "The researchers aimed to evaluate the evolving controversies and clinical approaches regarding Vitamin D supplementation in CKD patients, focusing on balancing its adverse effects against the prevention of severe secondary hyperparathyroidism.", "results_summary": "The study found that while Vitamin D deficiency is associated with poor outcomes in CKD patients, recent studies have tempered expectations about its supplementation benefits. Guidelines still support its use to avoid deficiency and manage secondary hyperparathyroidism, but complete normalization of PTH levels is not recommended.", "population_specificity": "Chronic kidney disease (CKD) patients.", "effective_dosage": "Not specified.", "study_duration": "Not specified.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:37:30.031399+00:00"}
{"study_id": 199537, "supplement_id": 1663, "safety_score": "Not Assessed", "efficacy_score": 50, "quality_score": 70, "study_goal": "The researchers aimed to investigate whether vitamin D affects COVID-19 disease burden by examining molecular studies of the vitamin D receptor (VDR) and its role in immune response against SARS-CoV-2.", "results_summary": "The study found mixed results regarding vitamin D's impact on COVID-19 severity, with some studies suggesting benefits in reducing severity and mortality, while others found no effect. It concluded that while vitamin D deficiency is not a prerequisite for severe COVID-19, vitamin D may help mitigate cytokine storms in severe cases.", "population_specificity": "Severe COVID-19 patients and individuals with non-functional VDR.", "effective_dosage": "Not available", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:37:31.671852+00:00"}
{"study_id": 199542, "supplement_id": 1663, "safety_score": "Not Assessed", "efficacy_score": 65, "quality_score": 70, "study_goal": "The researchers aimed to investigate the role of vitamin D status and metabolism in hypoparathyroidism (HypoPT) and assess the potential benefits of parent vitamin D supplementation.", "results_summary": "The study highlights the need for baseline evaluation of serum 25(OH)D levels in HypoPT patients and suggests supplementation with parent vitamin D to maintain levels of 30-50 ng/mL, though more data is needed to confirm its impact on metabolic control and disease manifestations.", "population_specificity": "Patients with hypoparathyroidism (HypoPT).", "effective_dosage": "Not specified (aims for serum 25(OH)D levels of 30-50 ng/mL).", "study_duration": "Not specified.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:37:34.919263+00:00"}
{"study_id": 199541, "supplement_id": 1663, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 90, "study_goal": "The researchers aimed to determine whether the effect of vitamin D on reducing type 2 diabetes risk differs among people of color and those with overweight/obesity compared to White individuals or those with normal weight.", "results_summary": "The study found that higher intratrial mean 25(OH)D concentrations (\u226540 ng/mL) significantly reduced diabetes risk in Black and White participants, with a similar trend in Asian participants. Participants with BMI <40 kg/m\u00b2 also showed reduced diabetes risk with higher 25(OH)D levels.", "population_specificity": "People with prediabetes, including Asian (n=130), Black (n=616), and White (n=1616) participants.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:37:35.283563+00:00"}
{"study_id": 199538, "supplement_id": 1663, "safety_score": "85", "efficacy_score": 60, "quality_score": 90, "study_goal": "The researchers aimed to investigate whether monthly supplementation of 60,000 IU vitamin D reduces fracture risk in adults and if intermittent doses are harmful.", "results_summary": "The study found no significant effect of vitamin D supplementation on overall fracture risk (HR 0.94), but suggested a potential long-term reduction in total fractures. No evidence supported concerns about increased fracture risk from monthly bolus doses.", "population_specificity": "Adults living in Australia, mean age 69.3 years, 45.7% women.", "effective_dosage": "60,000 IU monthly", "study_duration": "Median follow-up of 5.1 years", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:37:36.158235+00:00"}
{"study_id": 199540, "supplement_id": 1663, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 65, "study_goal": "The researchers aimed to determine whether vitamin D supplementation could enhance immune response in vitamin D-deficient women following COVID-19 vaccination.", "results_summary": "Vitamin D supplementation significantly increased serum 25-Hydroxy Vitamin D levels and IgG levels, with a positive correlation between final IgG and 25(OH)D levels. No significant difference in IgM levels was observed between supplemented and control groups.", "population_specificity": "Vitamin D-deficient women who received two doses of the COVID-19 vaccine (Pfizer-BioNTech or Sinovac).", "effective_dosage": "150,000 IU of vitamin D (single dose).", "study_duration": "Mean follow-up of more than 65 days.", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:37:37.361112+00:00"}
{"study_id": 199544, "supplement_id": 1663, "safety_score": "90", "efficacy_score": 20, "quality_score": 85, "study_goal": "The researchers aimed to determine if vitamin D supplementation could improve sputum smear and culture conversion rates and prevent relapse in patients with active pulmonary tuberculosis (PTB) in India.", "results_summary": "The study found no statistically significant difference in relapse rates or time to sputum smear and culture conversion between the vitamin D and placebo groups. Vitamin D supplementation did not show any beneficial effect in the treatment of PTB.", "population_specificity": "HIV-negative individuals aged 15-60 years with sputum smear-positive PTB in India.", "effective_dosage": "60,000 IU/sachet weekly for the first two months, fortnightly for the next four months, then monthly for the next 18 months.", "study_duration": "24 months", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:37:37.836918+00:00"}
{"study_id": 199522, "supplement_id": 1663, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 80, "study_goal": "The researchers aimed to evaluate recent genetic evidence related to micronutrients, particularly Vitamin D, and their association with COVID-19 severity and outcomes.", "results_summary": "The study found that Vitamin D supplementation may reduce COVID-19 severity and mortality, and identified specific VDR gene variants (rs2228570 \"f\" allele and rs7975232 \"aa\" genotype) as poor prognostic markers. Mendelian randomization studies did not find significant effects of genetically predicted micronutrient levels on COVID-19 phenotypes.", "population_specificity": "Patients infected with SARS-CoV-2 (COVID-19).", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:37:37.996574+00:00"}
{"study_id": 199545, "supplement_id": 1663, "safety_score": "90", "efficacy_score": 20, "quality_score": 85, "study_goal": "The researchers aimed to determine whether oral vitamin D supplementation could reduce psoriasis severity during winter months in individuals with low baseline vitamin D levels.", "results_summary": "The study found no significant difference in psoriasis severity between the vitamin D and placebo groups, as measured by PASI, Physician Global Assessment, self-administered PASI, and Dermatology Life Quality Index scores. No adverse effects were reported.", "population_specificity": "Adults from the general population in Troms\u00f8, Norway, with active plaque psoriasis and 25-hydroxyvitamin D levels below 24 ng/mL.", "effective_dosage": "100,000 IU loading dose followed by 20,000 IU/week.", "study_duration": "4 months.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:37:38.943943+00:00"}
{"study_id": 199546, "supplement_id": 1663, "safety_score": "Not Assessed", "efficacy_score": 60, "quality_score": 75, "study_goal": "The researchers aimed to evaluate the associations between vitamin D serum levels, supplementation, and clinical/radiological outcomes in patients with relapsing-remitting multiple sclerosis.", "results_summary": "The study found no statistically significant correlations between vitamin D serum levels or supplementation and clinical outcomes (disability status, relapses). However, fewer new T2-weighted lesions were observed in patients supplementing vitamin D.", "population_specificity": "133 patients with relapsing-remitting multiple sclerosis.", "effective_dosage": "Not specified", "study_duration": "24 months", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:37:41.119513+00:00"}
{"study_id": 199549, "supplement_id": 1663, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 80, "study_goal": "The researchers aimed to evaluate associations between 25OHD (vitamin D) levels and pulmonary health in children and young people with Cystic Fibrosis (cypCF).", "results_summary": "The meta-analysis indicated that higher 25OHD concentrations were significantly associated with improved lung function (FEV1) and reduced frequency of pulmonary exacerbations in cypCF. The study suggests a concentration of >75 nmol/L may slow lung function decline.", "population_specificity": "Children and young people with Cystic Fibrosis (aged \u226421 years) treated in pediatric settings.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:37:44.112394+00:00"}
{"study_id": 199550, "supplement_id": 1663, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to assess the reliability of vitamin D supplementation on clinical outcomes in diabetic foot ulcer patients through a meta-analysis.", "results_summary": "The pooled analysis showed significant improvements in ulcer area, serum vitamin D levels, total cholesterol, fasting plasma glucose, triglyceride, C-reactive protein, and HbA1c, but no significant effects on erythrocyte sedimentation rate and high-density lipoprotein levels. Vitamin D supplementation was found beneficial as an adjuvant treatment for diabetic foot ulcers.", "population_specificity": "Diabetic patients with foot ulcers (197 participants across 4 studies).", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:37:44.798158+00:00"}
{"study_id": 199551, "supplement_id": 1663, "safety_score": "Not Assessed", "efficacy_score": 70, "quality_score": 65, "study_goal": "The researchers aimed to review evidence on managing statin intolerance, including the potential role of Vitamin D in alleviating musculoskeletal effects.", "results_summary": "The study found that Vitamin D repletion may help alleviate the musculoskeletal effects of statins, such as myalgia, but did not provide specific efficacy data.", "population_specificity": "Individuals with statin intolerance, particularly those experiencing musculoskeletal symptoms.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:37:44.801057+00:00"}
{"study_id": 199548, "supplement_id": 1663, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 80, "study_goal": "The researchers aimed to investigate whether vitamin D supplementation could reduce the severity of dysmenorrhea and menstrual blood loss in young women with primary dysmenorrhea and vitamin D deficiency.", "results_summary": "Vitamin D supplementation significantly reduced dysmenorrhea severity (measured by VAS and VMS) and decreased pain-relief medication use (mefenamic acid) but had no significant effect on menstrual blood loss (measured by PBLAC).", "population_specificity": "Single female college students aged 18-25 with primary dysmenorrhea and vitamin D deficiency.", "effective_dosage": "300,000 IU (50,000 IU, two tablets every 8 hours) administered five days before the next menstrual cycle.", "study_duration": "Two successive menstrual cycles.", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:37:44.893597+00:00"}
{"study_id": 199552, "supplement_id": 1663, "safety_score": "Not Assessed", "efficacy_score": 45, "quality_score": 75, "study_goal": "The researchers aimed to clarify the gap between experimental and clinical evidence regarding vitamin D's role in cardiovascular health and its potential pleiotropic effects.", "results_summary": "The study found that while experimental evidence suggests vitamin D has non-classical pleiotropic effects on cardiovascular pathophysiology, clinical meta-analyses do not support its effectiveness in improving cardiovascular outcomes. It highlights the complexity of vitamin D signaling and potential reverse causation in observed correlations.", "population_specificity": "Not specified (general discussion of experimental and clinical findings).", "effective_dosage": "Not available", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:37:46.143059+00:00"}
{"study_id": 199554, "supplement_id": 1663, "safety_score": "Not Assessed", "efficacy_score": 20, "quality_score": 65, "study_goal": "The researchers aimed to evaluate the relationship between serum vitamin D levels and diarrhea risk.", "results_summary": "The study found weak or no evidence supporting a relationship between vitamin D levels and diarrhea risk, with six non-randomized studies showing no correlation and the only RCT failing to demonstrate any beneficial role of vitamin D.", "population_specificity": "5,545 participants across various study designs (RCT, cross-sectional, cohort, longitudinal/prospective, case-control).", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:37:46.765989+00:00"}
{"study_id": 199553, "supplement_id": 1663, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 85, "study_goal": "The researchers aimed to determine if higher-dose vitamin D supplementation in pregnancy reduces deficiency prevalence and prevents adverse outcomes like preeclampsia, fetal growth restriction, and gestational diabetes.", "results_summary": "The study is ongoing, but the abstract does not report final results. It outlines the methodology for assessing vitamin D levels and pregnancy outcomes, with the goal of informing future recommendations.", "population_specificity": "Pregnant women (10-14 weeks gestation) attending a national nuchal translucency scan program in Denmark.", "effective_dosage": "Control group: 10 \u00b5g/day; Intervention group: 90 \u00b5g/day.", "study_duration": "From enrollment (10-14 weeks gestation) until delivery.", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:37:47.725529+00:00"}
{"study_id": 199555, "supplement_id": 1663, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 90, "study_goal": "The researchers aimed to investigate the effect of vitamin D supplementation on serum 25(OH)D concentration and bone mineral density (BMD) in children and young adults with HIV infection.", "results_summary": "Vitamin D supplementation significantly increased serum 25(OH)D concentration at 12 months, and higher doses (1600-4000 IU/d) improved total BMD compared to standard doses (400-800 IU/d), though spine BMD showed no significant difference overall.", "population_specificity": "Children and young adults with HIV infection, aged 0-25 years.", "effective_dosage": "400-7000 IU/d (higher effective doses: 1600-4000 IU/d).", "study_duration": "6-24 months.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:37:50.570355+00:00"}
{"study_id": 199560, "supplement_id": 1663, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 65, "study_goal": "The researchers aimed to explore the role of vitamin D in geroprotection, focusing on its impact on cellular processes, immune response, and age-related diseases.", "results_summary": "The study highlights vitamin D's ability to modulate immune function, reduce inflammation, and potentially protect against age-related diseases, though translating findings into clinical practice remains challenging.", "population_specificity": "Older individuals (aging population)", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:37:52.528193+00:00"}
{"study_id": 199559, "supplement_id": 1663, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 80, "study_goal": "The researchers aimed to determine the association between serum vitamin D status and the risk of venous thromboembolism (VTE) in adults.", "results_summary": "The meta-analysis found a negative relationship between vitamin D levels and VTE risk, with higher vitamin D levels associated with lower VTE risk. The effect was statistically significant but further studies are needed to confirm the potential benefits of vitamin D supplementation.", "population_specificity": "Adults (general population, including individuals with neurological diseases).", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:37:52.957480+00:00"}
{"study_id": 199557, "supplement_id": 1663, "safety_score": "Not Assessed", "efficacy_score": 20, "quality_score": 75, "study_goal": "The researchers aimed to determine whether daily vitamin D supplementation during ICU stay improves clinically relevant outcomes in severe COVID-19 patients with low vitamin D levels.", "results_summary": "The study found no statistically significant difference in days spent on respiratory support or any secondary outcomes between the vitamin D supplementation group and the control group, suggesting no benefit of vitamin D in severe COVID-19 ICU patients.", "population_specificity": "Severe COVID-19 patients admitted to the ICU and in need of respiratory support with low vitamin D levels.", "effective_dosage": "Daily supplementation (exact dosage not specified)", "study_duration": "Duration of ICU stay (exact length not specified)", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:37:53.367908+00:00"}
{"study_id": 199556, "supplement_id": 1663, "safety_score": "90", "efficacy_score": 70, "quality_score": 85, "study_goal": "The researchers aimed to investigate the effects of high-dose Vitamin D supplementation on Vitamin D levels and metabolic profiles in obese children and adolescents with hypovitaminosis D.", "results_summary": "Supplementation with 6,000 IU Vitamin D daily for 12 weeks significantly increased Vitamin D levels, achieving sufficiency in 100% of the supplemented group, but showed no significant effects on weight loss, insulin resistance, lipid patterns, or blood pressure.", "population_specificity": "Children and adolescents (aged 12-18 years) with obesity (BMI >2.3 SDS) and hypovitaminosis D (Vitamin D level <20 \u00b5g/L).", "effective_dosage": "6,000 IU daily", "study_duration": "12 weeks", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:37:54.019470+00:00"}
{"study_id": 199562, "supplement_id": 1663, "safety_score": "Not Assessed", "efficacy_score": 30, "quality_score": 75, "study_goal": "The researchers aimed to evaluate the link between vitamin D status and cardiovascular health, as well as the effects of vitamin D supplementation on preventing cardiovascular diseases.", "results_summary": "Cross-sectional studies found associations between low vitamin D levels and cardiovascular conditions, but large interventional trials did not show benefits from supplementation in reducing ischemic events, heart failure, or hypertension. Some studies indicated potential benefits for insulin sensitivity and metabolic syndrome, but results were inconsistent.", "population_specificity": "Elderly individuals, particularly women, and general populations with cardiovascular risk factors.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:37:54.278878+00:00"}
{"study_id": 199564, "supplement_id": 1663, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 80, "study_goal": "The researchers aimed to determine whether oral vitamin D supplementation (including fortified foods) is associated with changes in body weight measures in children and adolescents.", "results_summary": "The study found a significant decrease in BMI and a significant weight gain following vitamin D supplementation in children and adolescents, though no significant change in height was observed. The effects may be linked to increased skeletal growth, but this requires further verification.", "population_specificity": "Children and adolescents", "effective_dosage": "Up to 600 IU/day", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:37:55.662245+00:00"}
{"study_id": 199563, "supplement_id": 1663, "safety_score": "85", "efficacy_score": 70, "quality_score": 90, "study_goal": "The researchers aimed to evaluate the role of vitamin D in immune system regulation and its potential protective effects against infections and auto-immune disorders.", "results_summary": "The study found an inverse relationship between vitamin D status and the risk of infections and auto-immune conditions, with supplementation showing modest benefits for acute respiratory infections, type 1 diabetes, and inflammatory bowel disease, particularly in deficient individuals. Meta-analyses of RCTs had mixed results, with stronger evidence from observational studies.", "population_specificity": "General population, with specific focus on individuals with vitamin D deficiency or at high risk of deficiency, children, and those with auto-immune conditions.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:37:56.422584+00:00"}
{"study_id": 199565, "supplement_id": 1663, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 85, "study_goal": "The researchers aimed to evaluate the efficacy of oral vitamin D supplementation in reducing BMI and improving lipid profiles in adolescents and young adults.", "results_summary": "The study found that a daily dose of 1000 IU of vitamin D increased serum 25(OH)D levels from 25.0 \u00b1 7.0 ng/ml to 31.0 \u00b1 10.0 ng/ml after 15 weeks. The effects on BMI and lipid profile were not detailed in the provided abstract.", "population_specificity": "Adolescents and young adults from a cohort in Bucaramanga, Colombia.", "effective_dosage": "1000 IU or 200 IU daily.", "study_duration": "15 weeks.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:37:59.664210+00:00"}
{"study_id": 199566, "supplement_id": 1663, "safety_score": "Not Assessed", "efficacy_score": 20, "quality_score": 65, "study_goal": "The researchers aimed to evaluate whether vitamin D supplementation prevents the conversion of prediabetes to diabetes and to suggest recommendations for future trial designs.", "results_summary": "Seven out of eight trials found no reduction in insulin resistance or risk of type 2 diabetes with vitamin D supplementation; only one trial showed improvements in fasting glucose and HOMA-IR.", "population_specificity": "Individuals with prediabetes", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:37:59.786461+00:00"}
{"study_id": 199567, "supplement_id": 1663, "safety_score": "Not Assessed", "efficacy_score": 60, "quality_score": 75, "study_goal": "The researchers aimed to evaluate the influence of vitamin D supplementation on mental health in adults with respiratory system diseases through a systematic review of randomized controlled trials.", "results_summary": "Three out of five included studies confirmed a beneficial effect of vitamin D on mental health in individuals with respiratory diseases, while two did not. The review concluded that the evidence is not strong enough to confirm a consistent beneficial effect.", "population_specificity": "Adults with respiratory system diseases, including chronic obstructive pulmonary disease, increased susceptibility to respiratory tract infections, pulmonary tuberculosis, and bronchial asthma.", "effective_dosage": "Varied from 4000 IU daily to 100,000 IU weekly or monthly.", "study_duration": "Ranged from 2 months to a year.", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:38:02.395811+00:00"}
{"study_id": 199568, "supplement_id": 1663, "safety_score": "Not Assessed", "efficacy_score": 60, "quality_score": 75, "study_goal": "The researchers aimed to systematically review RCTs assessing the influence of vitamin D supplementation on depression.", "results_summary": "Five studies supported a positive effect of vitamin D on depression, while three did not; overall, the systematic review did not strongly confirm its effectiveness.", "population_specificity": "Patients with major depressive disorders, general depression, bipolar depression, or postpartum depression.", "effective_dosage": "Daily doses of 1500 IU, 1600 IU, or 2800 IU; weekly/biweekly doses of 50,000 IU.", "study_duration": "Mostly 8 or 12 weeks; one study lasted 6 months.", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:38:02.430702+00:00"}
{"study_id": 199570, "supplement_id": 1663, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to evaluate the effect of vitamin D supplementation on improving urge urinary incontinence (UUI) and nocturia in postmenopausal women with vitamin D deficiency.", "results_summary": "The study found that weekly vitamin D supplementation significantly reduced the severity of UUI and frequency of nocturia, as well as their impact on daily life, compared to the control group.", "population_specificity": "Postmenopausal women with UUI or nocturia and vitamin D levels below 30 ng/ml.", "effective_dosage": "50,000 IU tablets weekly", "study_duration": "8 weeks", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:38:02.566996+00:00"}
{"study_id": 199571, "supplement_id": 1663, "safety_score": "Not Assessed", "efficacy_score": 30, "quality_score": 75, "study_goal": "The researchers aimed to assess whether vitamin D supplementation affects physical activity and fall risk in older adults with low baseline vitamin D levels.", "results_summary": "Physical activity declined and became more fragmented over time, with no clear benefit from vitamin D supplementation. The study did not demonstrate significant improvements in physical activity or fall risk reduction.", "population_specificity": "Adults aged 70+ with baseline serum 25(OH)D levels of 10-29 ng/mL and elevated fall risk.", "effective_dosage": "200 IU/day (control), 1000, 2000, or 4000 IU/day.", "study_duration": "Not specified in the abstract.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:38:04.264016+00:00"}
{"study_id": 199569, "supplement_id": 1663, "safety_score": "Not Assessed", "efficacy_score": 65, "quality_score": 75, "study_goal": "The researchers aimed to explore the molecular mechanisms of vitamin D's neuroprotective, anti-inflammatory, and prosurvival effects via the vitamin D receptor (VDR) and its potential role in neurodegenerative diseases like Parkinson's and Alzheimer's.", "results_summary": "The study suggests a link between vitamin D insufficiency and susceptibility to neurodegenerative diseases, highlighting VDR's role in prosurvival and anti-inflammatory pathways. However, the exact mechanisms remain unclear, and clinical studies show mixed results regarding vitamin D supplementation's efficacy in treating these diseases.", "population_specificity": "Preclinical and clinical studies, including those focused on Parkinson's and Alzheimer's diseases.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:38:04.368215+00:00"}
{"study_id": 199572, "supplement_id": 1663, "safety_score": "Not Assessed", "efficacy_score": null, "quality_score": 75, "study_goal": "The researchers aimed to compare the immunomodulatory effect of GAD-alum administered into lymph nodes versus placebo in Type 1 diabetes patients, focusing on those with the DR3DQ2 haplotype.", "results_summary": "The study found that patients with the DR3DQ2 haplotype had a distinct early cellular immune response to GAD-alum injections and higher GADA levels compared to placebo, suggesting better preservation of C-peptide.", "population_specificity": "Type 1 diabetes patients with the DR3DQ2 haplotype.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:38:05.471670+00:00"}
{"study_id": 199573, "supplement_id": 1663, "safety_score": "85", "efficacy_score": 45, "quality_score": 90, "study_goal": "The researchers aimed to assess whether vitamin D supplementation reduces hospitalization for infections.", "results_summary": "Vitamin D supplementation had little to no effect on hospitalization for infections overall but reduced extended hospitalizations (>6 days). The study found no significant protective effect against specific infection types.", "population_specificity": "46% women, mean age 69 years.", "effective_dosage": "60,000 international units monthly.", "study_duration": "Median follow-up of 5 years.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:38:06.972461+00:00"}
{"study_id": 199574, "supplement_id": 1663, "safety_score": "Not Assessed", "efficacy_score": 30, "quality_score": 75, "study_goal": "The researchers aimed to determine whether vitamin D supplementation shortened recovery delay in COVID-19 patients who remained RT-PCR positive on day 14.", "results_summary": "Vitamin D supplementation (200,000 IU) did not shorten recovery delay compared to placebo, with a longer median duration of viral RNA conversion in the intervention group (37 vs. 28 days, p=0.010). Ct values remained stable over time in both groups.", "population_specificity": "COVID-19 patients aged >18 years with confirmed RT-PCR positivity persisting on day 14.", "effective_dosage": "200,000 IU/1 ml of cholecalciferol (single dose).", "study_duration": "Not explicitly stated (follow-up until viral RNA conversion).", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:38:09.717606+00:00"}
{"study_id": 199576, "supplement_id": 1663, "safety_score": "Not Assessed", "efficacy_score": 50, "quality_score": 60, "study_goal": "The researchers aimed to review the current knowledge about the relationship between vitamin D and sepsis, and assess the potential value of vitamin D supplementation in sepsis patients with vitamin D deficiency.", "results_summary": "The abstract notes that previous research on the link between vitamin D deficiency and mortality in sepsis patients has been inconclusive, but suggests that adequate vitamin D levels may reduce mortality in severely deficient sepsis patients. Randomized controlled trials on vitamin D supplementation in this context are uncommon.", "population_specificity": "Sepsis patients with severe vitamin D deficiency.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:38:10.543705+00:00"}
{"study_id": 199577, "supplement_id": 1663, "safety_score": "Not Assessed", "efficacy_score": 65, "quality_score": 70, "study_goal": "The researchers aimed to explore the potential role of Vitamin D supplementation in regulating immune response and lung microbiota to mitigate pulmonary fibrosis.", "results_summary": "The study suggests that Vitamin D supplementation, among other immune-regulating treatments, showed initial effectiveness in reducing inflammatory responses linked to lung fibrosis. However, the specific impact of Vitamin D alone was not detailed.", "population_specificity": "Patients with idiopathic pulmonary fibrosis (IPF) and acute exacerbation-idiopathic pulmonary fibrosis (AE-IPF).", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:38:10.911665+00:00"}
{"study_id": 199575, "supplement_id": 1663, "safety_score": "90", "efficacy_score": 70, "quality_score": 85, "study_goal": "The researchers aimed to determine whether a higher dose (1000 IU vs. 400 IU per day) of vitamin D supplementation is necessary for bone mineral accretion in infants born with low serum 25(OH)D concentrations (<50 nmol/L).", "results_summary": "The study found no significant differences in whole-body or lumbar spine bone mineral content or density between infants receiving 1000 IU or 400 IU of vitamin D daily. However, serum 25(OH)D3 concentrations were significantly higher in the 1000 IU group from 3 to 12 months.", "population_specificity": "Healthy term singletons born with serum 25(OH)D concentrations <50 nmol/L in Greater Montreal, Quebec, Canada.", "effective_dosage": "1000 IU or 400 IU per day of oral vitamin D3.", "study_duration": "12 months (from age 1 to 12 months).", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:38:12.743256+00:00"}
{"study_id": 199579, "supplement_id": 1663, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 80, "study_goal": "The researchers aimed to determine whether vitamin D supplementation improves reproductive outcomes in infertile patients and how supplementation parameters affect clinical pregnancy rates.", "results_summary": "The meta-analysis found that vitamin D supplementation significantly increased clinical pregnancy rates in infertile women compared to controls (OR: 1.70, 95% CI: 1.24-2.34). However, larger sample sizes and higher-quality RCTs are needed to optimize supplementation parameters.", "population_specificity": "Infertile women (n=2352 across 12 studies).", "effective_dosage": "Moderate daily dosing (specific amounts not detailed in abstract).", "study_duration": "Not specified in abstract.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:38:13.140499+00:00"}
{"study_id": 199578, "supplement_id": 1663, "safety_score": "85", "efficacy_score": 30, "quality_score": 90, "study_goal": "To evaluate the effectiveness and safety of vitamin D or its hydroxylated metabolites in reducing severe asthma exacerbations and improving asthma symptom control.", "results_summary": "The study found no evidence that vitamin D supplementation reduces the risk of asthma exacerbations requiring systemic corticosteroids or improves asthma control. A single study on calcidiol showed positive results, but further research is needed.", "population_specificity": "Children and adults with asthma, aged 1 to 84 years, including subgroups under 5 years and 5-16 years.", "effective_dosage": "Not specified (varied across trials, primarily cholecalciferol).", "study_duration": "3 to 40 months.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:38:13.634023+00:00"}
{"study_id": 199580, "supplement_id": 1663, "safety_score": "85", "efficacy_score": 75, "quality_score": 80, "study_goal": "The researchers aimed to determine whether vitamin D supplements are effective and safe in reducing depressive symptoms compared to placebo in depressed patients.", "results_summary": "Vitamin D supplements were significantly superior to placebo in reducing depression, with a standardized mean difference of -0.49 (95% CI: -0.75 to -0.23). The study concluded that vitamin D is effective and safe for depressed patients, though data were heterogeneous.", "population_specificity": "Depressed patients (median age 39 years).", "effective_dosage": "Not specified in the abstract.", "study_duration": "Not specified in the abstract.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:38:14.351266+00:00"}
{"study_id": 199581, "supplement_id": 1663, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 80, "study_goal": "The researchers aimed to evaluate the effects and safety of vitamin D supplementation on gestational diabetes mellitus (GDM) patients and neonates to inform clinical treatment.", "results_summary": "Vitamin D supplementation in GDM patients increased serum 25(OH)D and HDL levels while reducing LDL, TG, and TC levels, and also reduced adverse neonatal outcomes.", "population_specificity": "1682 GDM patients (837 received vitamin D supplementation).", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:38:16.163883+00:00"}
{"study_id": 199582, "supplement_id": 1663, "safety_score": "Not Assessed", "efficacy_score": 70, "quality_score": 80, "study_goal": "The researchers aimed to summarize current knowledge on the immunomodulatory effects of Vitamin D and zinc, particularly in the context of obesity-related immune dysfunction.", "results_summary": "The abstract suggests that Vitamin D has immunomodulatory roles and may improve innate immune cell function in obesity, but it does not provide specific results or data on its efficacy. Future research is recommended to explore supplementation strategies.", "population_specificity": "Individuals with obesity and associated micronutrient deficiencies.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:38:18.326073+00:00"}
{"study_id": 199583, "supplement_id": 1663, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 65, "study_goal": "The researchers aimed to evaluate the effects of vitamin D supplementation on peripheral neuropathy severity in multiple myeloma patients with inadequate vitamin D levels.", "results_summary": "Median 25(OH)D levels significantly increased after 6 months of supplementation, with 66% achieving adequate levels. Additionally, 37% of participants experienced a reduction in peripheral neuropathy severity.", "population_specificity": "Multiple myeloma patients with inadequate vitamin D levels (<75 nmol/L).", "effective_dosage": "Not specified", "study_duration": "6 months", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:38:18.446562+00:00"}
{"study_id": 199585, "supplement_id": 1663, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 78, "study_goal": "The researchers aimed to evaluate the effect of vitamin D supplementation on serum 25(OH)D and HOMA-IR levels in non-diabetic pregnant women to assess its potential role in mitigating insulin resistance.", "results_summary": "Vitamin D supplementation significantly increased 25(OH)D levels and decreased HOMA-IR levels in non-diabetic pregnant women, with higher doses further reducing HOMA-IR but not affecting 25(OH)D concentrations.", "population_specificity": "Non-diabetic pregnant women", "effective_dosage": "High weekly dose (specific amount not detailed in abstract)", "study_duration": "Not specified in abstract", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:38:20.772602+00:00"}
{"study_id": 199584, "supplement_id": 1663, "safety_score": "90", "efficacy_score": 60, "quality_score": 85, "study_goal": "The researchers aimed to determine whether high-dose cholecalciferol supplementation reduces extraskeletal complications (diabetes mellitus, major cardiovascular events, cancer, and death) in renal transplant recipients with low vitamin D levels.", "results_summary": "High-dose cholecalciferol significantly increased serum 25(OH) vitamin D levels but did not reduce the composite endpoint of extraskeletal complications. However, it reduced symptomatic fractures compared to low-dose supplementation.", "population_specificity": "Nondiabetic adult renal transplant recipients with serum 25(OH) vitamin D levels <30 ng/mL, 12 to 48 months post-transplantation.", "effective_dosage": "High dose (100,000 IU every 2 weeks for 2 months, then monthly for 22 months) and low dose (12,000 IU same schedule).", "study_duration": "24 months", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:38:21.750169+00:00"}
{"study_id": 199588, "supplement_id": 1663, "safety_score": "Not Assessed", "efficacy_score": 30, "quality_score": 20, "study_goal": "The researchers aimed to evaluate the effects of vitamin D on irritable bowel syndrome symptoms and associated quality of life.", "results_summary": "The study identified methodological errors in the review, including inadequate search strategy, GRADE misassessment, and misinterpretation, suggesting that addressing these limitations could lead to more robust findings.", "population_specificity": "Not specified (abstract refers to a review of pooled effects).", "effective_dosage": "Not available", "study_duration": "Not available", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:38:22.708029+00:00"}
{"study_id": 199587, "supplement_id": 1663, "safety_score": "90", "efficacy_score": 85, "quality_score": 88, "study_goal": "The researchers aimed to assess the efficacy and safety of long-term monthly calcifediol versus cholecalciferol in treating vitamin D deficiency in postmenopausal women.", "results_summary": "The study found that both calcifediol and cholecalciferol effectively raised and maintained 25(OH)D levels, with calcifediol showing a faster onset of action. Treatment withdrawal led to a rapid decline in vitamin D levels, and no significant safety concerns were reported.", "population_specificity": "Postmenopausal women with vitamin D deficiency (25(OH)D < 20 ng/mL).", "effective_dosage": "Calcifediol 0.266 mg/month or cholecalciferol 25,000 IU (0.625 mg)/month.", "study_duration": "12 months.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:38:23.455914+00:00"}
{"study_id": 199589, "supplement_id": 1663, "safety_score": "Not Assessed", "efficacy_score": 65, "quality_score": 70, "study_goal": "The researchers aimed to evaluate the association between vitamin D insufficiency (25(OH)D <30 ng/mL) and sepsis severity, as well as the risk of hospitalisation in emergency department septic patients.", "results_summary": "The study found a significant negative association between vitamin D levels and sepsis severity (measured by APACHE-II and MEDS scores), but vitamin D insufficiency did not predict hospitalisation risk. The prevalence of vitamin D insufficiency was high (87%) among the studied septic patients.", "population_specificity": "101 emergency department septic patients aged \u226518 years in a tertiary hospital in Bangkok, Thailand.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:38:25.518667+00:00"}
{"study_id": 199591, "supplement_id": 1663, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 85, "study_goal": "The researchers aimed to assess the effect of vitamin D supplementation on glycemic control in patients with type 2 diabetes.", "results_summary": "The meta-analysis found that vitamin D supplementation significantly reduced HbA1c, fasting plasma glucose (FPG), and HOMA-IR in type 2 diabetes patients, particularly in those with deficient vitamin D status. The effect was most pronounced with higher doses and shorter intervention periods, though substantial heterogeneity and potential publication bias were noted.", "population_specificity": "Type 2 diabetes patients, especially those with deficient vitamin D status.", "effective_dosage": "Higher doses (specific amounts not detailed in the abstract).", "study_duration": "Short intervention period (specific duration not detailed in the abstract).", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:38:27.429420+00:00"}
{"study_id": 199590, "supplement_id": 1663, "safety_score": "Not Assessed", "efficacy_score": 60, "quality_score": 85, "study_goal": "The researchers aimed to determine whether antenatal or early-life vitamin D levels, intake, or supplementation are associated with the development of eczema or food allergy in childhood.", "results_summary": "The study found no evidence that vitamin D supplementation during pregnancy affects eczema incidence, but higher cord blood vitamin D levels were associated with reduced eczema risk in cohort studies. Further trials are needed to confirm if supplementation can prevent eczema or food allergy.", "population_specificity": "Pregnant women and infants (early-life and antenatal focus)", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:38:27.820922+00:00"}
{"study_id": 199592, "supplement_id": 1663, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to compare the effectiveness of calcifediol (25-hydroxyvitamin D) versus vitamin D itself in preventing or treating vitamin D deficiency.", "results_summary": "Calcifediol was found to have higher intestinal absorption (nearly 100%) and immediate circulation accessibility compared to vitamin D, especially in cases of fat malabsorption or post-bariatric surgery. It was 3-8 times more potent than vitamin D in raising serum 25OHD levels, depending on baseline levels and dosage.", "population_specificity": "Individuals with vitamin D deficiency, particularly those with fat malabsorption, post-bariatric surgery, or impaired liver 25-hydroxylase activity.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:38:30.031298+00:00"}
{"study_id": 199593, "supplement_id": 1663, "safety_score": "Not Assessed", "efficacy_score": null, "quality_score": 85, "study_goal": "The study aims to assess school readiness in children born to HIV-infected women previously enrolled in a maternal vitamin D supplementation trial, identifying contributing biological, environmental, and social factors.", "results_summary": "The abstract does not report specific findings on Vitamin D's effects, as it focuses on the study design and planned assessments of school readiness in HIV-exposed children.", "population_specificity": "Pregnant women living with HIV in Dar es Salaam, Tanzania, and their children aged 3-6.5 years.", "effective_dosage": "Not specified", "study_duration": "Follow-up from pregnancy up to 1-year postpartum (parent trial); current study assesses children aged 3-6.5 years.", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:38:31.476649+00:00"}
{"study_id": 199595, "supplement_id": 1663, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 80, "study_goal": "The researchers aimed to investigate the effect of vitamin D supplementation on depressive symptoms in type 2 diabetic patients.", "results_summary": "Vitamin D supplementation was significantly more effective than placebo in improving depressive symptoms in type 2 diabetic patients, with a meta-analysis showing statistical significance (95% CI: -0.70 to -0.08, p = 0.01). Two out of three studies confirmed its effectiveness.", "population_specificity": "Type 2 diabetic patients with depression.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:38:31.574092+00:00"}
{"study_id": 199594, "supplement_id": 1663, "safety_score": "90", "efficacy_score": 40, "quality_score": 70, "study_goal": "To evaluate the efficacy and safety of vitamin D supplementation as an adjunct to antibiotics for the treatment of acute childhood pneumonia.", "results_summary": "Vitamin D probably has little or no effect on the time to resolution of acute illness, and the evidence is uncertain regarding its impact on duration of hospitalization or mortality rate. No major adverse events were reported.", "population_specificity": "Children aged one month to five years hospitalized with acute community-acquired pneumonia.", "effective_dosage": "Single bolus doses (100,000 IU or 300,000 IU), daily doses (1000 IU or 2000 IU for five days), or variable doses (20,000\u2013100,000 IU followed by 10,000 IU/day for four days or until discharge).", "study_duration": "Varied by trial, from a single dose to five days of supplementation.", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:38:32.931344+00:00"}
{"study_id": 199596, "supplement_id": 1663, "safety_score": "Not Assessed", "efficacy_score": 30, "quality_score": 65, "study_goal": "The researchers aimed to compare vitamin D plasma concentrations and gut microbiome composition in adult women with IBS versus healthy controls, and assess potential associations.", "results_summary": "The study found no significant difference in vitamin D deficiency or insufficiency rates between IBS and healthy groups, nor any association between vitamin D levels and gut microbiome diversity or specific bacterial abundances.", "population_specificity": "Adult women with irritable bowel syndrome (IBS) and healthy controls (HC).", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:38:33.320622+00:00"}
{"study_id": 199599, "supplement_id": 1663, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 85, "study_goal": "The researchers aimed to evaluate the effects of Vitamin D supplementation on COVID-19-related outcomes through a systematic review and meta-analysis.", "results_summary": "The study found that Vitamin D supplementation had a significant impact on improving COVID-19-related outcomes, though the exact nature and magnitude of these effects were not detailed in the abstract. The meta-analysis suggested consistent benefits across multiple studies.", "population_specificity": "Not specified in the abstract.", "effective_dosage": "Not specified in the abstract.", "study_duration": "Not specified in the abstract.", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:38:36.090516+00:00"}
{"study_id": 199597, "supplement_id": 1663, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 85, "study_goal": "The researchers aimed to determine whether daily vitamin D3 supplementation at 5000 IU reduces influenza-like illness (ILI), including COVID-19, in healthcare workers.", "results_summary": "Vitamin D3 supplementation was associated with a lower risk of ILI, including COVID-19, among healthcare workers compared to the control group. The study reported an incidence rate difference of -1.7 \u00d7 10, suggesting a protective effect.", "population_specificity": "Healthcare workers at a tertiary university hospital (255 in the intervention group, 2827 in the control group).", "effective_dosage": "5000 IU daily", "study_duration": "Nine months", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:38:36.329447+00:00"}
{"study_id": 199601, "supplement_id": 1663, "safety_score": "30", "efficacy_score": 20, "quality_score": 85, "study_goal": "The researchers aimed to determine whether high-dose vitamin D supplementation reduces fractures and adverse cardiovascular or non-skeletal outcomes in a predominantly non-Western population at increased cardiovascular risk.", "results_summary": "High-dose vitamin D did not reduce fractures or secondary composite outcomes (CV events, cancer, falls). The vitamin D group showed higher mortality compared to placebo.", "population_specificity": "Predominantly South Asian (53.5%), South East Asian (33.6%), and South American (8.5%) participants without vascular disease but at increased CV risk.", "effective_dosage": "60,000 IU monthly", "study_duration": "Mean follow-up of 4.6 years", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:38:40.503828+00:00"}
{"study_id": 199605, "supplement_id": 1663, "safety_score": "Not Assessed", "efficacy_score": 50, "quality_score": 75, "study_goal": "The researchers aimed to determine whether the effects of vitamin D varied based on baseline kidney function (eGFR).", "results_summary": "The study found no significant differences in the effects of vitamin D based on baseline eGFR levels. The abstract does not specify the nature or direction of these effects.", "population_specificity": "15,917 participants with a mean age of 68 years, 51% women.", "effective_dosage": "Not available", "study_duration": "Not available", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:38:41.134839+00:00"}
{"study_id": 199603, "supplement_id": 1663, "safety_score": "Not Assessed", "efficacy_score": 65, "quality_score": 75, "study_goal": "The researchers aimed to explore the role of vitamin D deficiency in CKD-induced muscle atrophy and its potential as a therapeutic target.", "results_summary": "The abstract suggests vitamin D deficiency is a contributing factor to muscle atrophy in CKD patients, but it does not provide specific efficacy data on vitamin D supplementation. The review highlights potential treatments, including nutritional supplementation, but lacks detailed outcomes for vitamin D.", "population_specificity": "Chronic kidney disease (CKD) patients with muscle atrophy or sarcopenia.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:38:41.185692+00:00"}
